id	sid	tid	token	lemma	pos
ajlm-2617	1	1	abstract	abstract	ADJ
ajlm-2617	1	2	introduction	introduction	NOUN
ajlm-2617	1	3	ethical	ethical	ADJ
ajlm-2617	1	4	considerations	consideration	NOUN
ajlm-2617	1	5	case	case	NOUN
ajlm-2617	1	6	presentation	presentation	NOUN
ajlm-2617	1	7	management	management	NOUN
ajlm-2617	1	8	and	and	CCONJ
ajlm-2617	1	9	outcomes	outcome	NOUN
ajlm-2617	1	10	discussion	discussion	NOUN
ajlm-2617	1	11	acknowledgements	acknowledgement	NOUN
ajlm-2617	1	12	references	reference	NOUN
ajlm-2617	1	13	about	about	ADP
ajlm-2617	1	14	the	the	DET
ajlm-2617	1	15	author(s	author(s	NOUN
ajlm-2617	1	16	)	)	PUNCT
ajlm-2617	1	17	stephanie	stephanie	PROPN
ajlm-2617	1	18	j.	j.	PROPN
ajlm-2617	1	19	kennedy	kennedy	PROPN
ajlm-2617	1	20	department	department	PROPN
ajlm-2617	1	21	of	of	ADP
ajlm-2617	1	22	haematology	haematology	NOUN
ajlm-2617	1	23	and	and	CCONJ
ajlm-2617	1	24	cell	cell	NOUN
ajlm-2617	1	25	biology	biology	NOUN
ajlm-2617	1	26	,	,	PUNCT
ajlm-2617	1	27	faculty	faculty	NOUN
ajlm-2617	1	28	of	of	ADP
ajlm-2617	1	29	health	health	NOUN
ajlm-2617	1	30	sciences	sciences	PROPN
ajlm-2617	1	31	,	,	PUNCT
ajlm-2617	1	32	university	university	NOUN
ajlm-2617	1	33	of	of	ADP
ajlm-2617	1	34	the	the	DET
ajlm-2617	1	35	free	free	ADJ
ajlm-2617	1	36	state	state	PROPN
ajlm-2617	1	37	,	,	PUNCT
ajlm-2617	1	38	bloemfontein	bloemfontein	PROPN
ajlm-2617	1	39	,	,	PUNCT
ajlm-2617	1	40	south	south	PROPN
ajlm-2617	1	41	africa	africa	PROPN
ajlm-2617	1	42	department	department	PROPN
ajlm-2617	1	43	of	of	ADP
ajlm-2617	1	44	haematology	haematology	PROPN
ajlm-2617	1	45	,	,	PUNCT
ajlm-2617	1	46	national	national	PROPN
ajlm-2617	1	47	health	health	PROPN
ajlm-2617	1	48	laboratory	laboratory	PROPN
ajlm-2617	1	49	service	service	PROPN
ajlm-2617	1	50	,	,	PUNCT
ajlm-2617	1	51	bloemfontein	bloemfontein	PROPN
ajlm-2617	1	52	,	,	PUNCT
ajlm-2617	1	53	south	south	PROPN
ajlm-2617	1	54	africa	africa	PROPN
ajlm-2617	1	55	anne	anne	PROPN
ajlm-2617	1	56	-	-	PUNCT
ajlm-2617	1	57	cecilia	cecilia	PROPN
ajlm-2617	1	58	van	van	PROPN
ajlm-2617	1	59	marle	marle	PROPN
ajlm-2617	1	60	department	department	PROPN
ajlm-2617	1	61	of	of	ADP
ajlm-2617	1	62	haematology	haematology	NOUN
ajlm-2617	1	63	and	and	CCONJ
ajlm-2617	1	64	cell	cell	NOUN
ajlm-2617	1	65	biology	biology	NOUN
ajlm-2617	1	66	,	,	PUNCT
ajlm-2617	1	67	faculty	faculty	NOUN
ajlm-2617	1	68	of	of	ADP
ajlm-2617	1	69	health	health	NOUN
ajlm-2617	1	70	sciences	sciences	PROPN
ajlm-2617	1	71	,	,	PUNCT
ajlm-2617	1	72	university	university	NOUN
ajlm-2617	1	73	of	of	ADP
ajlm-2617	1	74	the	the	DET
ajlm-2617	1	75	free	free	ADJ
ajlm-2617	1	76	state	state	PROPN
ajlm-2617	1	77	,	,	PUNCT
ajlm-2617	1	78	bloemfontein	bloemfontein	PROPN
ajlm-2617	1	79	,	,	PUNCT
ajlm-2617	1	80	south	south	PROPN
ajlm-2617	1	81	africa	africa	PROPN
ajlm-2617	1	82	department	department	PROPN
ajlm-2617	1	83	of	of	ADP
ajlm-2617	1	84	haematology	haematology	PROPN
ajlm-2617	1	85	,	,	PUNCT
ajlm-2617	1	86	national	national	PROPN
ajlm-2617	1	87	health	health	PROPN
ajlm-2617	1	88	laboratory	laboratory	PROPN
ajlm-2617	1	89	service	service	PROPN
ajlm-2617	1	90	,	,	PUNCT
ajlm-2617	1	91	bloemfontein	bloemfontein	PROPN
ajlm-2617	1	92	,	,	PUNCT
ajlm-2617	1	93	south	south	PROPN
ajlm-2617	1	94	africa	africa	PROPN
ajlm-2617	1	95	citation	citation	PROPN
ajlm-2617	1	96	kennedy	kennedy	PROPN
ajlm-2617	1	97	sj	sj	PROPN
ajlm-2617	1	98	,	,	PUNCT
ajlm-2617	1	99	van	van	PROPN
ajlm-2617	1	100	marle	marle	PROPN
ajlm-2617	1	101	a	a	PROPN
ajlm-2617	1	102	-	-	PUNCT
ajlm-2617	1	103	c.	c.	NOUN
ajlm-2617	1	104	pseudomonocytosis	pseudomonocytosis	NOUN
ajlm-2617	1	105	on	on	ADP
ajlm-2617	1	106	a	a	DET
ajlm-2617	1	107	sysmex	sysmex	NOUN
ajlm-2617	1	108	xn	xn	PROPN
ajlm-2617	1	109	haematology	haematology	NOUN
ajlm-2617	1	110	analyser	analyser	NOUN
ajlm-2617	1	111	masking	mask	VERB
ajlm-2617	1	112	the	the	DET
ajlm-2617	1	113	monocytopenia	monocytopenia	NOUN
ajlm-2617	1	114	of	of	ADP
ajlm-2617	1	115	hairy	hairy	ADJ
ajlm-2617	1	116	cell	cell	NOUN
ajlm-2617	1	117	leukaemia	leukaemia	NOUN
ajlm-2617	1	118	in	in	ADP
ajlm-2617	1	119	a	a	DET
ajlm-2617	1	120	south	south	ADJ
ajlm-2617	1	121	african	african	ADJ
ajlm-2617	1	122	woman	woman	NOUN
ajlm-2617	1	123	.	.	PUNCT
ajlm-2617	2	1	afr	afr	PROPN
ajlm-2617	2	2	j	j	PROPN
ajlm-2617	2	3	lab	lab	PROPN
ajlm-2617	2	4	med	med	PROPN
ajlm-2617	2	5	.	.	PUNCT
ajlm-2617	3	1	2025;14(1	2025;14(1	NUM
ajlm-2617	3	2	)	)	PUNCT
ajlm-2617	3	3	,	,	PUNCT
ajlm-2617	3	4	a2617	a2617	PROPN
ajlm-2617	3	5	.	.	PROPN
ajlm-2617	3	6	https://doi.org/10.4102/ajlm.v14i1.2617	https://doi.org/10.4102/ajlm.v14i1.2617	NOUN
ajlm-2617	3	7	case	case	NOUN
ajlm-2617	3	8	study	study	NOUN
ajlm-2617	3	9	pseudomonocytosis	pseudomonocytosis	NOUN
ajlm-2617	3	10	on	on	ADP
ajlm-2617	3	11	a	a	DET
ajlm-2617	3	12	sysmex	sysmex	NOUN
ajlm-2617	3	13	xn	xn	PROPN
ajlm-2617	3	14	haematology	haematology	NOUN
ajlm-2617	3	15	analyser	analyser	NOUN
ajlm-2617	3	16	masking	mask	VERB
ajlm-2617	3	17	the	the	DET
ajlm-2617	3	18	monocytopenia	monocytopenia	NOUN
ajlm-2617	3	19	of	of	ADP
ajlm-2617	3	20	hairy	hairy	ADJ
ajlm-2617	3	21	cell	cell	NOUN
ajlm-2617	3	22	leukaemia	leukaemia	NOUN
ajlm-2617	3	23	in	in	ADP
ajlm-2617	3	24	a	a	DET
ajlm-2617	3	25	south	south	ADJ
ajlm-2617	3	26	african	african	ADJ
ajlm-2617	3	27	woman	woman	NOUN
ajlm-2617	3	28	stephanie	stephanie	PROPN
ajlm-2617	3	29	j.	j.	PROPN
ajlm-2617	3	30	kennedy	kennedy	PROPN
ajlm-2617	3	31	,	,	PUNCT
ajlm-2617	3	32	anne	anne	PROPN
ajlm-2617	3	33	-	-	PUNCT
ajlm-2617	3	34	cecilia	cecilia	PROPN
ajlm-2617	3	35	van	van	PROPN
ajlm-2617	3	36	marle	marle	PROPN
ajlm-2617	3	37	received	receive	VERB
ajlm-2617	3	38	:	:	PUNCT
ajlm-2617	3	39	30	30	NUM
ajlm-2617	3	40	aug	aug	NOUN
ajlm-2617	3	41	.	.	PROPN
ajlm-2617	3	42	2024	2024	NUM
ajlm-2617	3	43	;	;	PUNCT
ajlm-2617	3	44	accepted	accept	VERB
ajlm-2617	3	45	:	:	PUNCT
ajlm-2617	3	46	09	09	NUM
ajlm-2617	3	47	dec	dec	PROPN
ajlm-2617	3	48	.	.	PROPN
ajlm-2617	3	49	2024	2024	NUM
ajlm-2617	3	50	;	;	PUNCT
ajlm-2617	3	51	published	publish	VERB
ajlm-2617	3	52	:	:	PUNCT
ajlm-2617	3	53	25	25	NUM
ajlm-2617	3	54	mar	mar	PROPN
ajlm-2617	3	55	.	.	PROPN
ajlm-2617	4	1	2025	2025	NUM
ajlm-2617	4	2	copyright	copyright	NOUN
ajlm-2617	4	3	:	:	PUNCT
ajlm-2617	4	4	©	©	PROPN
ajlm-2617	4	5	2025	2025	NUM
ajlm-2617	4	6	.	.	PUNCT
ajlm-2617	5	1	the	the	DET
ajlm-2617	5	2	author(s	author(s	PROPN
ajlm-2617	5	3	)	)	PUNCT
ajlm-2617	5	4	.	.	PUNCT
ajlm-2617	6	1	licensee	licensee	NOUN
ajlm-2617	6	2	:	:	PUNCT
ajlm-2617	6	3	aosis	aosis	NOUN
ajlm-2617	6	4	.	.	PUNCT
ajlm-2617	7	1	this	this	PRON
ajlm-2617	7	2	is	be	AUX
ajlm-2617	7	3	an	an	DET
ajlm-2617	7	4	open	open	ADJ
ajlm-2617	7	5	access	access	NOUN
ajlm-2617	7	6	article	article	NOUN
ajlm-2617	7	7	distributed	distribute	VERB
ajlm-2617	7	8	under	under	ADP
ajlm-2617	7	9	the	the	DET
ajlm-2617	7	10	terms	term	NOUN
ajlm-2617	7	11	of	of	ADP
ajlm-2617	7	12	the	the	DET
ajlm-2617	7	13	creative	creative	ADJ
ajlm-2617	7	14	commons	common	NOUN
ajlm-2617	7	15	attribution	attribution	NOUN
ajlm-2617	7	16	license	license	NOUN
ajlm-2617	7	17	,	,	PUNCT
ajlm-2617	7	18	which	which	PRON
ajlm-2617	7	19	permits	permit	VERB
ajlm-2617	7	20	unrestricted	unrestricted	ADJ
ajlm-2617	7	21	use	use	NOUN
ajlm-2617	7	22	,	,	PUNCT
ajlm-2617	7	23	distribution	distribution	NOUN
ajlm-2617	7	24	,	,	PUNCT
ajlm-2617	7	25	and	and	CCONJ
ajlm-2617	7	26	reproduction	reproduction	NOUN
ajlm-2617	7	27	in	in	ADP
ajlm-2617	7	28	any	any	DET
ajlm-2617	7	29	medium	medium	NOUN
ajlm-2617	7	30	,	,	PUNCT
ajlm-2617	7	31	provided	provide	VERB
ajlm-2617	7	32	the	the	DET
ajlm-2617	7	33	original	original	ADJ
ajlm-2617	7	34	work	work	NOUN
ajlm-2617	7	35	is	be	AUX
ajlm-2617	7	36	properly	properly	ADV
ajlm-2617	7	37	cited	cite	VERB
ajlm-2617	7	38	.	.	PUNCT
ajlm-2617	8	1	abstract	abstract	ADJ
ajlm-2617	8	2	introduction	introduction	NOUN
ajlm-2617	8	3	:	:	PUNCT
ajlm-2617	8	4	hairy	hairy	ADJ
ajlm-2617	8	5	cell	cell	NOUN
ajlm-2617	8	6	leukaemia	leukaemia	NOUN
ajlm-2617	8	7	(	(	PUNCT
ajlm-2617	8	8	hcl	hcl	PROPN
ajlm-2617	8	9	)	)	PUNCT
ajlm-2617	8	10	is	be	AUX
ajlm-2617	8	11	a	a	DET
ajlm-2617	8	12	rare	rare	ADJ
ajlm-2617	8	13	b	b	NOUN
ajlm-2617	8	14	-	-	PUNCT
ajlm-2617	8	15	cell	cell	NOUN
ajlm-2617	8	16	lymphoproliferative	lymphoproliferative	ADJ
ajlm-2617	8	17	disorder	disorder	NOUN
ajlm-2617	8	18	characterised	characterise	VERB
ajlm-2617	8	19	by	by	ADP
ajlm-2617	8	20	medium	medium	ADJ
ajlm-2617	8	21	-	-	PUNCT
ajlm-2617	8	22	sized	sized	ADJ
ajlm-2617	8	23	villous	villous	ADJ
ajlm-2617	8	24	lymphocytes	lymphocyte	NOUN
ajlm-2617	8	25	(	(	PUNCT
ajlm-2617	8	26	‘	'	PUNCT
ajlm-2617	8	27	hairy	hairy	ADJ
ajlm-2617	8	28	cells	cell	NOUN
ajlm-2617	8	29	’	'	PUNCT
ajlm-2617	8	30	)	)	PUNCT
ajlm-2617	8	31	and	and	CCONJ
ajlm-2617	8	32	monocytopenia	monocytopenia	NOUN
ajlm-2617	8	33	in	in	ADP
ajlm-2617	8	34	the	the	DET
ajlm-2617	8	35	peripheral	peripheral	ADJ
ajlm-2617	8	36	blood	blood	NOUN
ajlm-2617	8	37	.	.	PUNCT
ajlm-2617	9	1	automated	automate	VERB
ajlm-2617	9	2	full	full	ADJ
ajlm-2617	9	3	blood	blood	NOUN
ajlm-2617	9	4	count	count	NOUN
ajlm-2617	9	5	(	(	PUNCT
ajlm-2617	9	6	fbc	fbc	PROPN
ajlm-2617	9	7	)	)	PUNCT
ajlm-2617	9	8	haematology	haematology	NOUN
ajlm-2617	9	9	analysers	analyser	NOUN
ajlm-2617	9	10	may	may	AUX
ajlm-2617	9	11	spuriously	spuriously	ADV
ajlm-2617	9	12	count	count	VERB
ajlm-2617	9	13	‘	'	PUNCT
ajlm-2617	9	14	hairy	hairy	ADJ
ajlm-2617	9	15	cells	cell	NOUN
ajlm-2617	9	16	’	'	PUNCT
ajlm-2617	9	17	as	as	ADP
ajlm-2617	9	18	monocytes	monocyte	NOUN
ajlm-2617	9	19	,	,	PUNCT
ajlm-2617	9	20	resulting	result	VERB
ajlm-2617	9	21	in	in	ADP
ajlm-2617	9	22	pseudomonocytosis	pseudomonocytosis	NOUN
ajlm-2617	9	23	.	.	PUNCT
ajlm-2617	10	1	case	case	NOUN
ajlm-2617	10	2	presentation	presentation	NOUN
ajlm-2617	10	3	:	:	PUNCT
ajlm-2617	10	4	a	a	DET
ajlm-2617	10	5	72	72	NUM
ajlm-2617	10	6	-	-	PUNCT
ajlm-2617	10	7	year	year	NOUN
ajlm-2617	10	8	-	-	PUNCT
ajlm-2617	10	9	old	old	ADJ
ajlm-2617	10	10	woman	woman	NOUN
ajlm-2617	10	11	presented	present	VERB
ajlm-2617	10	12	with	with	ADP
ajlm-2617	10	13	symptomatic	symptomatic	ADJ
ajlm-2617	10	14	anaemia	anaemia	NOUN
ajlm-2617	10	15	and	and	CCONJ
ajlm-2617	10	16	massive	massive	ADJ
ajlm-2617	10	17	splenomegaly	splenomegaly	NOUN
ajlm-2617	10	18	to	to	ADP
ajlm-2617	10	19	a	a	DET
ajlm-2617	10	20	regional	regional	ADJ
ajlm-2617	10	21	hospital	hospital	NOUN
ajlm-2617	10	22	in	in	ADP
ajlm-2617	10	23	north	north	PROPN
ajlm-2617	10	24	west	west	PROPN
ajlm-2617	10	25	province	province	PROPN
ajlm-2617	10	26	,	,	PUNCT
ajlm-2617	10	27	south	south	PROPN
ajlm-2617	10	28	africa	africa	PROPN
ajlm-2617	10	29	,	,	PUNCT
ajlm-2617	10	30	in	in	ADP
ajlm-2617	10	31	june	june	PROPN
ajlm-2617	10	32	2023	2023	NUM
ajlm-2617	10	33	.	.	PUNCT
ajlm-2617	11	1	an	an	DET
ajlm-2617	11	2	fbc	fbc	PROPN
ajlm-2617	11	3	and	and	CCONJ
ajlm-2617	11	4	differential	differential	ADJ
ajlm-2617	11	5	count	count	NOUN
ajlm-2617	11	6	,	,	PUNCT
ajlm-2617	11	7	performed	perform	VERB
ajlm-2617	11	8	on	on	ADP
ajlm-2617	11	9	a	a	DET
ajlm-2617	11	10	sysmex	sysmex	NOUN
ajlm-2617	11	11	xn	xn	NOUN
ajlm-2617	11	12	-	-	PUNCT
ajlm-2617	11	13	series	series	NOUN
ajlm-2617	11	14	haematology	haematology	NOUN
ajlm-2617	11	15	analyser	analyser	NOUN
ajlm-2617	11	16	,	,	PUNCT
ajlm-2617	11	17	revealed	reveal	VERB
ajlm-2617	11	18	a	a	DET
ajlm-2617	11	19	monocytosis	monocytosis	NOUN
ajlm-2617	11	20	of	of	ADP
ajlm-2617	11	21	42.82	42.82	NUM
ajlm-2617	11	22	×	×	NOUN
ajlm-2617	11	23	109	109	NUM
ajlm-2617	11	24	/	/	SYM
ajlm-2617	11	25	l.	l.	PROPN
ajlm-2617	11	26	however	however	ADV
ajlm-2617	11	27	,	,	PUNCT
ajlm-2617	11	28	a	a	DET
ajlm-2617	11	29	manual	manual	ADJ
ajlm-2617	11	30	differential	differential	ADJ
ajlm-2617	11	31	count	count	NOUN
ajlm-2617	11	32	,	,	PUNCT
ajlm-2617	11	33	peripheral	peripheral	ADJ
ajlm-2617	11	34	blood	blood	NOUN
ajlm-2617	11	35	microscopy	microscopy	NOUN
ajlm-2617	11	36	,	,	PUNCT
ajlm-2617	11	37	and	and	CCONJ
ajlm-2617	11	38	multiparameter	multiparameter	NOUN
ajlm-2617	11	39	flow	flow	NOUN
ajlm-2617	11	40	cytometry	cytometry	PROPN
ajlm-2617	11	41	confirmed	confirm	VERB
ajlm-2617	11	42	a	a	DET
ajlm-2617	11	43	monocytopenia	monocytopenia	NOUN
ajlm-2617	11	44	with	with	ADP
ajlm-2617	11	45	numerous	numerous	ADJ
ajlm-2617	11	46	‘	'	PUNCT
ajlm-2617	11	47	hairy	hairy	ADJ
ajlm-2617	11	48	cells	cell	NOUN
ajlm-2617	11	49	’	'	PUNCT
ajlm-2617	11	50	.	.	PUNCT
ajlm-2617	12	1	management	management	NOUN
ajlm-2617	12	2	and	and	CCONJ
ajlm-2617	12	3	outcome	outcome	NOUN
ajlm-2617	12	4	:	:	PUNCT
ajlm-2617	12	5	the	the	DET
ajlm-2617	12	6	patient	patient	NOUN
ajlm-2617	12	7	was	be	AUX
ajlm-2617	12	8	referred	refer	VERB
ajlm-2617	12	9	to	to	ADP
ajlm-2617	12	10	a	a	DET
ajlm-2617	12	11	tertiary	tertiary	ADJ
ajlm-2617	12	12	hospital	hospital	NOUN
ajlm-2617	12	13	where	where	SCONJ
ajlm-2617	12	14	bone	bone	NOUN
ajlm-2617	12	15	marrow	marrow	NOUN
ajlm-2617	12	16	morphology	morphology	NOUN
ajlm-2617	12	17	and	and	CCONJ
ajlm-2617	12	18	a	a	DET
ajlm-2617	12	19	brafv600e	brafv600e	ADJ
ajlm-2617	12	20	mutation	mutation	NOUN
ajlm-2617	12	21	confirmed	confirm	VERB
ajlm-2617	12	22	a	a	DET
ajlm-2617	12	23	diagnosis	diagnosis	NOUN
ajlm-2617	12	24	of	of	ADP
ajlm-2617	12	25	hcl	hcl	PROPN
ajlm-2617	12	26	.	.	PUNCT
ajlm-2617	13	1	unfortunately	unfortunately	ADV
ajlm-2617	13	2	,	,	PUNCT
ajlm-2617	13	3	she	she	PRON
ajlm-2617	13	4	demised	demise	VERB
ajlm-2617	13	5	shortly	shortly	ADV
ajlm-2617	13	6	after	after	ADP
ajlm-2617	13	7	admission	admission	NOUN
ajlm-2617	13	8	.	.	PUNCT
ajlm-2617	14	1	conclusion	conclusion	NOUN
ajlm-2617	14	2	:	:	PUNCT
ajlm-2617	14	3	here	here	ADV
ajlm-2617	14	4	,	,	PUNCT
ajlm-2617	14	5	we	we	PRON
ajlm-2617	14	6	report	report	VERB
ajlm-2617	14	7	a	a	DET
ajlm-2617	14	8	case	case	NOUN
ajlm-2617	14	9	of	of	ADP
ajlm-2617	14	10	hcl	hcl	PROPN
ajlm-2617	14	11	where	where	SCONJ
ajlm-2617	14	12	a	a	DET
ajlm-2617	14	13	sysmex	sysmex	NOUN
ajlm-2617	14	14	xn	xn	NOUN
ajlm-2617	14	15	-	-	PUNCT
ajlm-2617	14	16	series	series	NOUN
ajlm-2617	14	17	artifactually	artifactually	ADV
ajlm-2617	14	18	counted	count	VERB
ajlm-2617	14	19	‘	'	PUNCT
ajlm-2617	14	20	hairy	hairy	ADJ
ajlm-2617	14	21	cells	cell	NOUN
ajlm-2617	14	22	’	'	PUNCT
ajlm-2617	14	23	as	as	ADP
ajlm-2617	14	24	monocytes	monocyte	NOUN
ajlm-2617	14	25	,	,	PUNCT
ajlm-2617	14	26	masking	mask	VERB
ajlm-2617	14	27	the	the	DET
ajlm-2617	14	28	characteristic	characteristic	ADJ
ajlm-2617	14	29	monocytopenia	monocytopenia	PROPN
ajlm-2617	14	30	.	.	PUNCT
ajlm-2617	15	1	with	with	ADP
ajlm-2617	15	2	the	the	DET
ajlm-2617	15	3	recent	recent	ADJ
ajlm-2617	15	4	introduction	introduction	NOUN
ajlm-2617	15	5	of	of	ADP
ajlm-2617	15	6	sysmex	sysmex	NOUN
ajlm-2617	15	7	xn	xn	NOUN
ajlm-2617	15	8	-	-	PUNCT
ajlm-2617	15	9	series	series	NOUN
ajlm-2617	15	10	fbc	fbc	PROPN
ajlm-2617	15	11	haematology	haematology	PROPN
ajlm-2617	15	12	analysers	analyser	NOUN
ajlm-2617	15	13	(	(	PUNCT
ajlm-2617	15	14	sysmex	sysmex	NOUN
ajlm-2617	15	15	corporation	corporation	NOUN
ajlm-2617	15	16	,	,	PUNCT
ajlm-2617	15	17	kobe	kobe	PROPN
ajlm-2617	15	18	,	,	PUNCT
ajlm-2617	15	19	japan	japan	PROPN
ajlm-2617	15	20	)	)	PUNCT
ajlm-2617	15	21	in	in	ADP
ajlm-2617	15	22	national	national	PROPN
ajlm-2617	15	23	health	health	PROPN
ajlm-2617	15	24	laboratory	laboratory	NOUN
ajlm-2617	15	25	service	service	NOUN
ajlm-2617	15	26	laboratories	laboratory	NOUN
ajlm-2617	15	27	across	across	ADP
ajlm-2617	15	28	south	south	PROPN
ajlm-2617	15	29	africa	africa	PROPN
ajlm-2617	15	30	,	,	PUNCT
ajlm-2617	15	31	we	we	PRON
ajlm-2617	15	32	urge	urge	VERB
ajlm-2617	15	33	operators	operator	NOUN
ajlm-2617	15	34	to	to	PART
ajlm-2617	15	35	be	be	AUX
ajlm-2617	15	36	cognisant	cognisant	ADJ
ajlm-2617	15	37	of	of	ADP
ajlm-2617	15	38	the	the	DET
ajlm-2617	15	39	inherent	inherent	ADJ
ajlm-2617	15	40	limitations	limitation	NOUN
ajlm-2617	15	41	of	of	ADP
ajlm-2617	15	42	fbc	fbc	PROPN
ajlm-2617	15	43	analysers	analyser	NOUN
ajlm-2617	15	44	in	in	ADP
ajlm-2617	15	45	generating	generate	VERB
ajlm-2617	15	46	blood	blood	NOUN
ajlm-2617	15	47	counts	count	NOUN
ajlm-2617	15	48	.	.	PUNCT
ajlm-2617	16	1	what	what	PRON
ajlm-2617	16	2	this	this	DET
ajlm-2617	16	3	study	study	NOUN
ajlm-2617	16	4	adds	add	VERB
ajlm-2617	16	5	:	:	PUNCT
ajlm-2617	16	6	even	even	ADV
ajlm-2617	16	7	modern	modern	ADJ
ajlm-2617	16	8	automated	automate	VERB
ajlm-2617	16	9	laboratory	laboratory	NOUN
ajlm-2617	16	10	analysers	analyser	NOUN
ajlm-2617	16	11	with	with	ADP
ajlm-2617	16	12	advanced	advanced	ADJ
ajlm-2617	16	13	technologies	technology	NOUN
ajlm-2617	16	14	have	have	VERB
ajlm-2617	16	15	inherent	inherent	ADJ
ajlm-2617	16	16	limitations	limitation	NOUN
ajlm-2617	16	17	.	.	PUNCT
ajlm-2617	17	1	this	this	DET
ajlm-2617	17	2	case	case	NOUN
ajlm-2617	17	3	highlights	highlight	VERB
ajlm-2617	17	4	the	the	DET
ajlm-2617	17	5	importance	importance	NOUN
ajlm-2617	17	6	of	of	ADP
ajlm-2617	17	7	a	a	DET
ajlm-2617	17	8	manual	manual	ADJ
ajlm-2617	17	9	differential	differential	ADJ
ajlm-2617	17	10	count	count	NOUN
ajlm-2617	17	11	and	and	CCONJ
ajlm-2617	17	12	peripheral	peripheral	ADJ
ajlm-2617	17	13	blood	blood	NOUN
ajlm-2617	17	14	smear	smear	NOUN
ajlm-2617	17	15	review	review	NOUN
ajlm-2617	17	16	in	in	ADP
ajlm-2617	17	17	the	the	DET
ajlm-2617	17	18	era	era	NOUN
ajlm-2617	17	19	of	of	ADP
ajlm-2617	17	20	automation	automation	NOUN
ajlm-2617	17	21	.	.	PUNCT
ajlm-2617	18	1	keywords	keyword	NOUN
ajlm-2617	18	2	:	:	PUNCT
ajlm-2617	18	3	hairy	hairy	ADJ
ajlm-2617	18	4	cell	cell	NOUN
ajlm-2617	18	5	leukaemia	leukaemia	NOUN
ajlm-2617	18	6	;	;	PUNCT
ajlm-2617	18	7	pseudomonocytosis	pseudomonocytosis	NOUN
ajlm-2617	18	8	;	;	PUNCT
ajlm-2617	18	9	monocytopenia	monocytopenia	NOUN
ajlm-2617	18	10	;	;	PUNCT
ajlm-2617	18	11	haematology	haematology	NOUN
ajlm-2617	18	12	full	full	ADJ
ajlm-2617	18	13	blood	blood	NOUN
ajlm-2617	18	14	count	count	NOUN
ajlm-2617	18	15	analyser	analyser	NOUN
ajlm-2617	18	16	;	;	PUNCT
ajlm-2617	18	17	sysmex	sysmex	NOUN
ajlm-2617	18	18	xn	xn	NOUN
ajlm-2617	18	19	-	-	PUNCT
ajlm-2617	18	20	series	series	NOUN
ajlm-2617	18	21	.	.	PUNCT
ajlm-2617	19	1	introduction	introduction	NOUN
ajlm-2617	19	2	hairy	hairy	ADJ
ajlm-2617	19	3	cell	cell	NOUN
ajlm-2617	19	4	leukaemia	leukaemia	NOUN
ajlm-2617	19	5	(	(	PUNCT
ajlm-2617	19	6	hcl	hcl	PROPN
ajlm-2617	19	7	)	)	PUNCT
ajlm-2617	19	8	is	be	AUX
ajlm-2617	19	9	a	a	DET
ajlm-2617	19	10	rare	rare	ADJ
ajlm-2617	19	11	b	b	NOUN
ajlm-2617	19	12	-	-	PUNCT
ajlm-2617	19	13	cell	cell	NOUN
ajlm-2617	19	14	lymphoproliferative	lymphoproliferative	ADJ
ajlm-2617	19	15	disorder	disorder	NOUN
ajlm-2617	19	16	accounting	account	VERB
ajlm-2617	19	17	for	for	ADP
ajlm-2617	19	18	approximately	approximately	ADV
ajlm-2617	19	19	2	2	NUM
ajlm-2617	19	20	%	%	NOUN
ajlm-2617	19	21	of	of	ADP
ajlm-2617	19	22	lymphoid	lymphoid	NOUN
ajlm-2617	19	23	leukaemias	leukaemia	NOUN
ajlm-2617	19	24	,	,	PUNCT
ajlm-2617	19	25	and	and	CCONJ
ajlm-2617	19	26	usually	usually	ADV
ajlm-2617	19	27	involves	involve	VERB
ajlm-2617	19	28	the	the	DET
ajlm-2617	19	29	bone	bone	NOUN
ajlm-2617	19	30	marrow	marrow	NOUN
ajlm-2617	19	31	(	(	PUNCT
ajlm-2617	19	32	bm	bm	PROPN
ajlm-2617	19	33	)	)	PUNCT
ajlm-2617	19	34	,	,	PUNCT
ajlm-2617	19	35	splenic	splenic	ADJ
ajlm-2617	19	36	red	red	ADJ
ajlm-2617	19	37	pulp	pulp	NOUN
ajlm-2617	19	38	,	,	PUNCT
ajlm-2617	19	39	and	and	CCONJ
ajlm-2617	19	40	peripheral	peripheral	ADJ
ajlm-2617	19	41	blood	blood	NOUN
ajlm-2617	19	42	(	(	PUNCT
ajlm-2617	19	43	pb).1	pb).1	ADV
ajlm-2617	19	44	although	although	SCONJ
ajlm-2617	19	45	lymphocytosis	lymphocytosis	NOUN
ajlm-2617	19	46	is	be	AUX
ajlm-2617	19	47	uncommon	uncommon	ADJ
ajlm-2617	19	48	in	in	ADP
ajlm-2617	19	49	hcl	hcl	PROPN
ajlm-2617	19	50	(	(	PUNCT
ajlm-2617	19	51	5	5	NUM
ajlm-2617	19	52	%	%	NOUN
ajlm-2617	19	53	–	–	PUNCT
ajlm-2617	19	54	10	10	NUM
ajlm-2617	19	55	%	%	NOUN
ajlm-2617	19	56	)	)	PUNCT
ajlm-2617	19	57	,	,	PUNCT
ajlm-2617	19	58	circulating	circulate	VERB
ajlm-2617	19	59	‘	'	PUNCT
ajlm-2617	19	60	hairy	hairy	ADJ
ajlm-2617	19	61	cells	cell	NOUN
ajlm-2617	19	62	’	'	PUNCT
ajlm-2617	19	63	,	,	PUNCT
ajlm-2617	19	64	albeit	albeit	SCONJ
ajlm-2617	19	65	at	at	ADP
ajlm-2617	19	66	low	low	ADJ
ajlm-2617	19	67	numbers	number	NOUN
ajlm-2617	19	68	,	,	PUNCT
ajlm-2617	19	69	are	be	AUX
ajlm-2617	19	70	characteristic	characteristic	ADJ
ajlm-2617	19	71	(	(	PUNCT
ajlm-2617	19	72	85%).1	85%).1	NUM
ajlm-2617	19	73	variable	variable	ADJ
ajlm-2617	19	74	cytopenias	cytopenia	NOUN
ajlm-2617	19	75	are	be	AUX
ajlm-2617	19	76	a	a	DET
ajlm-2617	19	77	frequent	frequent	ADJ
ajlm-2617	19	78	laboratory	laboratory	NOUN
ajlm-2617	19	79	feature	feature	NOUN
ajlm-2617	19	80	,	,	PUNCT
ajlm-2617	19	81	whilst	whilst	SCONJ
ajlm-2617	19	82	monocytopenia	monocytopenia	NOUN
ajlm-2617	19	83	is	be	AUX
ajlm-2617	19	84	almost	almost	ADV
ajlm-2617	19	85	always	always	ADV
ajlm-2617	19	86	present	present	ADJ
ajlm-2617	19	87	(	(	PUNCT
ajlm-2617	19	88	98%).1,2	98%).1,2	NUM
ajlm-2617	19	89	an	an	DET
ajlm-2617	19	90	accurate	accurate	ADJ
ajlm-2617	19	91	automated	automate	VERB
ajlm-2617	19	92	white	white	ADJ
ajlm-2617	19	93	blood	blood	NOUN
ajlm-2617	19	94	cell	cell	NOUN
ajlm-2617	19	95	(	(	PUNCT
ajlm-2617	19	96	wbc	wbc	NOUN
ajlm-2617	19	97	)	)	PUNCT
ajlm-2617	19	98	differential	differential	NOUN
ajlm-2617	19	99	count	count	NOUN
ajlm-2617	19	100	demonstrating	demonstrate	VERB
ajlm-2617	19	101	monocytopenia	monocytopenia	NOUN
ajlm-2617	19	102	should	should	AUX
ajlm-2617	19	103	trigger	trigger	VERB
ajlm-2617	19	104	a	a	DET
ajlm-2617	19	105	suspicion	suspicion	NOUN
ajlm-2617	19	106	of	of	ADP
ajlm-2617	19	107	hcl	hcl	PROPN
ajlm-2617	19	108	and	and	CCONJ
ajlm-2617	19	109	warrants	warrant	NOUN
ajlm-2617	19	110	careful	careful	ADJ
ajlm-2617	19	111	morphologic	morphologic	ADJ
ajlm-2617	19	112	assessment	assessment	NOUN
ajlm-2617	19	113	for	for	ADP
ajlm-2617	19	114	‘	'	PUNCT
ajlm-2617	19	115	hairy	hairy	ADJ
ajlm-2617	19	116	cells’.3,4	cells’.3,4	ADJ
ajlm-2617	19	117	however	however	ADV
ajlm-2617	19	118	,	,	PUNCT
ajlm-2617	19	119	certain	certain	ADJ
ajlm-2617	19	120	automated	automated	ADJ
ajlm-2617	19	121	full	full	ADJ
ajlm-2617	19	122	blood	blood	NOUN
ajlm-2617	19	123	count	count	NOUN
ajlm-2617	19	124	(	(	PUNCT
ajlm-2617	19	125	fbc	fbc	PROPN
ajlm-2617	19	126	)	)	PUNCT
ajlm-2617	19	127	haematology	haematology	NOUN
ajlm-2617	19	128	analysers	analyser	NOUN
ajlm-2617	19	129	may	may	AUX
ajlm-2617	19	130	misidentify	misidentify	VERB
ajlm-2617	19	131	‘	'	PUNCT
ajlm-2617	19	132	hairy	hairy	ADJ
ajlm-2617	19	133	cells	cell	NOUN
ajlm-2617	19	134	’	'	PUNCT
ajlm-2617	19	135	as	as	ADP
ajlm-2617	19	136	monocytes	monocyte	NOUN
ajlm-2617	19	137	,	,	PUNCT
ajlm-2617	19	138	resulting	result	VERB
ajlm-2617	19	139	in	in	ADP
ajlm-2617	19	140	pseudomonocytosis.5,6	pseudomonocytosis.5,6	NOUN
ajlm-2617	19	141	in	in	ADP
ajlm-2617	19	142	2022	2022	NUM
ajlm-2617	19	143	,	,	PUNCT
ajlm-2617	19	144	the	the	DET
ajlm-2617	19	145	national	national	PROPN
ajlm-2617	19	146	health	health	PROPN
ajlm-2617	19	147	laboratory	laboratory	PROPN
ajlm-2617	19	148	service	service	NOUN
ajlm-2617	19	149	(	(	PUNCT
ajlm-2617	19	150	nhls	nhls	PROPN
ajlm-2617	19	151	)	)	PUNCT
ajlm-2617	19	152	and	and	CCONJ
ajlm-2617	19	153	roche	roche	NOUN
ajlm-2617	19	154	diagnostics	diagnostic	NOUN
ajlm-2617	19	155	(	(	PUNCT
ajlm-2617	19	156	pty	pty	NOUN
ajlm-2617	19	157	)	)	PUNCT
ajlm-2617	19	158	ltd	ltd	PROPN
ajlm-2617	19	159	entered	enter	VERB
ajlm-2617	19	160	into	into	ADP
ajlm-2617	19	161	a	a	DET
ajlm-2617	19	162	service	service	NOUN
ajlm-2617	19	163	level	level	NOUN
ajlm-2617	19	164	agreement	agreement	NOUN
ajlm-2617	19	165	for	for	ADP
ajlm-2617	19	166	the	the	DET
ajlm-2617	19	167	placement	placement	NOUN
ajlm-2617	19	168	of	of	ADP
ajlm-2617	19	169	sysmex	sysmex	NOUN
ajlm-2617	19	170	xn	xn	NOUN
ajlm-2617	19	171	-	-	PUNCT
ajlm-2617	19	172	series	series	NOUN
ajlm-2617	19	173	automated	automate	VERB
ajlm-2617	19	174	fbc	fbc	PROPN
ajlm-2617	19	175	haematology	haematology	NOUN
ajlm-2617	19	176	analysers	analyser	NOUN
ajlm-2617	19	177	(	(	PUNCT
ajlm-2617	19	178	sysmex	sysmex	NOUN
ajlm-2617	19	179	corporation	corporation	NOUN
ajlm-2617	19	180	,	,	PUNCT
ajlm-2617	19	181	kobe	kobe	PROPN
ajlm-2617	19	182	,	,	PUNCT
ajlm-2617	19	183	japan	japan	PROPN
ajlm-2617	19	184	)	)	PUNCT
ajlm-2617	19	185	in	in	ADP
ajlm-2617	19	186	nhls	nhls	ADJ
ajlm-2617	19	187	laboratories	laboratory	NOUN
ajlm-2617	19	188	(	(	PUNCT
ajlm-2617	19	189	n	n	NOUN
ajlm-2617	19	190	=	=	SYM
ajlm-2617	19	191	146	146	NUM
ajlm-2617	19	192	)	)	PUNCT
ajlm-2617	19	193	across	across	ADP
ajlm-2617	19	194	south	south	PROPN
ajlm-2617	19	195	africa	africa	PROPN
ajlm-2617	19	196	.	.	PUNCT
ajlm-2617	20	1	this	this	DET
ajlm-2617	20	2	national	national	ADJ
ajlm-2617	20	3	roll	roll	NOUN
ajlm-2617	20	4	-	-	PUNCT
ajlm-2617	20	5	out	out	NOUN
ajlm-2617	20	6	involved	involve	VERB
ajlm-2617	20	7	the	the	DET
ajlm-2617	20	8	placement	placement	NOUN
ajlm-2617	20	9	of	of	ADP
ajlm-2617	20	10	the	the	DET
ajlm-2617	20	11	sysmex	sysmex	NOUN
ajlm-2617	20	12	xn-1000	xn-1000	PROPN
ajlm-2617	20	13	series	series	PROPN
ajlm-2617	20	14	in	in	ADP
ajlm-2617	20	15	medium	medium	NOUN
ajlm-2617	20	16	(	(	PUNCT
ajlm-2617	20	17	n	n	NOUN
ajlm-2617	20	18	=	=	SYM
ajlm-2617	20	19	51	51	NUM
ajlm-2617	20	20	)	)	PUNCT
ajlm-2617	20	21	and	and	CCONJ
ajlm-2617	20	22	large	large	ADJ
ajlm-2617	20	23	laboratories	laboratory	NOUN
ajlm-2617	20	24	(	(	PUNCT
ajlm-2617	20	25	n	n	NOUN
ajlm-2617	20	26	=	=	NUM
ajlm-2617	20	27	20	20	NUM
ajlm-2617	20	28	)	)	PUNCT
ajlm-2617	20	29	and	and	CCONJ
ajlm-2617	20	30	xn	xn	PROPN
ajlm-2617	20	31	-	-	ADJ
ajlm-2617	20	32	l	l	NOUN
ajlm-2617	20	33	530	530	NUM
ajlm-2617	20	34	instruments	instrument	NOUN
ajlm-2617	20	35	in	in	ADP
ajlm-2617	20	36	smaller	small	ADJ
ajlm-2617	20	37	laboratories	laboratory	NOUN
ajlm-2617	20	38	(	(	PUNCT
ajlm-2617	20	39	n	n	NOUN
ajlm-2617	20	40	=	=	SYM
ajlm-2617	20	41	75).7	75).7	NUM
ajlm-2617	20	42	automated	automate	VERB
ajlm-2617	20	43	fbc	fbc	PROPN
ajlm-2617	20	44	haematology	haematology	NOUN
ajlm-2617	20	45	analysers	analyser	NOUN
ajlm-2617	20	46	generate	generate	VERB
ajlm-2617	20	47	valuable	valuable	ADJ
ajlm-2617	20	48	quantitative	quantitative	ADJ
ajlm-2617	20	49	and	and	CCONJ
ajlm-2617	20	50	qualitative	qualitative	ADJ
ajlm-2617	20	51	information	information	NOUN
ajlm-2617	20	52	that	that	PRON
ajlm-2617	20	53	can	can	AUX
ajlm-2617	20	54	assist	assist	VERB
ajlm-2617	20	55	laboratory	laboratory	NOUN
ajlm-2617	20	56	staff	staff	NOUN
ajlm-2617	20	57	with	with	ADP
ajlm-2617	20	58	the	the	DET
ajlm-2617	20	59	accurate	accurate	ADJ
ajlm-2617	20	60	interpretation	interpretation	NOUN
ajlm-2617	20	61	of	of	ADP
ajlm-2617	20	62	fbc	fbc	PROPN
ajlm-2617	20	63	results	result	NOUN
ajlm-2617	20	64	,	,	PUNCT
ajlm-2617	20	65	as	as	ADV
ajlm-2617	20	66	well	well	ADV
ajlm-2617	20	67	as	as	ADP
ajlm-2617	20	68	alert	alert	VERB
ajlm-2617	20	69	them	they	PRON
ajlm-2617	20	70	to	to	PART
ajlm-2617	20	71	prioritise	prioritise	VERB
ajlm-2617	20	72	abnormal	abnormal	ADJ
ajlm-2617	20	73	samples	sample	NOUN
ajlm-2617	20	74	for	for	ADP
ajlm-2617	20	75	pb	pb	ADP
ajlm-2617	20	76	smear	smear	NOUN
ajlm-2617	20	77	review.8,9	review.8,9	PROPN
ajlm-2617	20	78	not	not	PART
ajlm-2617	20	79	all	all	DET
ajlm-2617	20	80	nhls	nhls	ADJ
ajlm-2617	20	81	laboratories	laboratory	NOUN
ajlm-2617	20	82	are	be	AUX
ajlm-2617	20	83	staffed	staff	VERB
ajlm-2617	20	84	with	with	ADP
ajlm-2617	20	85	pathologists	pathologist	NOUN
ajlm-2617	20	86	.	.	PUNCT
ajlm-2617	21	1	therefore	therefore	ADV
ajlm-2617	21	2	,	,	PUNCT
ajlm-2617	21	3	technologists	technologist	NOUN
ajlm-2617	21	4	and	and	CCONJ
ajlm-2617	21	5	technicians	technician	NOUN
ajlm-2617	21	6	frequently	frequently	ADV
ajlm-2617	21	7	rely	rely	VERB
ajlm-2617	21	8	on	on	ADP
ajlm-2617	21	9	automated	automate	VERB
ajlm-2617	21	10	analyser	analyser	NOUN
ajlm-2617	21	11	data	datum	NOUN
ajlm-2617	21	12	to	to	PART
ajlm-2617	21	13	guide	guide	VERB
ajlm-2617	21	14	referral	referral	NOUN
ajlm-2617	21	15	for	for	ADP
ajlm-2617	21	16	microscopy	microscopy	NOUN
ajlm-2617	21	17	.	.	PUNCT
ajlm-2617	22	1	ethical	ethical	ADJ
ajlm-2617	22	2	considerations	consideration	NOUN
ajlm-2617	22	3	ethical	ethical	ADJ
ajlm-2617	22	4	clearance	clearance	NOUN
ajlm-2617	22	5	was	be	AUX
ajlm-2617	22	6	obtained	obtain	VERB
ajlm-2617	22	7	from	from	ADP
ajlm-2617	22	8	the	the	DET
ajlm-2617	22	9	health	health	NOUN
ajlm-2617	22	10	science	science	PROPN
ajlm-2617	22	11	research	research	PROPN
ajlm-2617	22	12	ethics	ethic	NOUN
ajlm-2617	22	13	committee	committee	PROPN
ajlm-2617	22	14	of	of	ADP
ajlm-2617	22	15	the	the	DET
ajlm-2617	22	16	university	university	NOUN
ajlm-2617	22	17	of	of	ADP
ajlm-2617	22	18	the	the	DET
ajlm-2617	22	19	free	free	ADJ
ajlm-2617	22	20	state	state	NOUN
ajlm-2617	22	21	(	(	PUNCT
ajlm-2617	22	22	reference	reference	NOUN
ajlm-2617	22	23	no	no	INTJ
ajlm-2617	22	24	.	.	PUNCT
ajlm-2617	22	25	:	:	PUNCT
ajlm-2617	22	26	ufs	ufs	NOUN
ajlm-2617	22	27	-	-	NOUN
ajlm-2617	22	28	hsd2024/1295	hsd2024/1295	NOUN
ajlm-2617	22	29	)	)	PUNCT
ajlm-2617	22	30	.	.	PUNCT
ajlm-2617	23	1	the	the	DET
ajlm-2617	23	2	patient	patient	NOUN
ajlm-2617	23	3	’s	’s	PART
ajlm-2617	23	4	results	result	NOUN
ajlm-2617	23	5	were	be	AUX
ajlm-2617	23	6	pseudonymised	pseudonymise	VERB
ajlm-2617	23	7	to	to	PART
ajlm-2617	23	8	ensure	ensure	VERB
ajlm-2617	23	9	patient	patient	ADJ
ajlm-2617	23	10	confidentiality	confidentiality	NOUN
ajlm-2617	23	11	and	and	CCONJ
ajlm-2617	23	12	stored	store	VERB
ajlm-2617	23	13	securely	securely	ADV
ajlm-2617	23	14	on	on	ADP
ajlm-2617	23	15	a	a	DET
ajlm-2617	23	16	password	password	NOUN
ajlm-2617	23	17	-	-	PUNCT
ajlm-2617	23	18	protected	protect	VERB
ajlm-2617	23	19	computer	computer	NOUN
ajlm-2617	23	20	only	only	ADV
ajlm-2617	23	21	accessible	accessible	ADJ
ajlm-2617	23	22	by	by	ADP
ajlm-2617	23	23	the	the	DET
ajlm-2617	23	24	authors	author	NOUN
ajlm-2617	23	25	.	.	PUNCT
ajlm-2617	24	1	attempts	attempt	NOUN
ajlm-2617	24	2	to	to	PART
ajlm-2617	24	3	locate	locate	VERB
ajlm-2617	24	4	the	the	DET
ajlm-2617	24	5	patient	patient	NOUN
ajlm-2617	24	6	or	or	CCONJ
ajlm-2617	24	7	their	their	PRON
ajlm-2617	24	8	next	next	ADJ
ajlm-2617	24	9	of	of	ADP
ajlm-2617	24	10	kin	kin	PROPN
ajlm-2617	24	11	to	to	PART
ajlm-2617	24	12	obtain	obtain	VERB
ajlm-2617	24	13	permission	permission	NOUN
ajlm-2617	24	14	to	to	PART
ajlm-2617	24	15	publish	publish	VERB
ajlm-2617	24	16	this	this	DET
ajlm-2617	24	17	report	report	NOUN
ajlm-2617	24	18	were	be	AUX
ajlm-2617	24	19	unsuccessful	unsuccessful	ADJ
ajlm-2617	24	20	.	.	PUNCT
ajlm-2617	25	1	case	case	NOUN
ajlm-2617	25	2	presentation	presentation	NOUN
ajlm-2617	25	3	a	a	DET
ajlm-2617	25	4	72	72	NUM
ajlm-2617	25	5	-	-	PUNCT
ajlm-2617	25	6	year	year	NOUN
ajlm-2617	25	7	-	-	PUNCT
ajlm-2617	25	8	old	old	ADJ
ajlm-2617	25	9	woman	woman	NOUN
ajlm-2617	25	10	presented	present	VERB
ajlm-2617	25	11	with	with	ADP
ajlm-2617	25	12	symptomatic	symptomatic	ADJ
ajlm-2617	25	13	anaemia	anaemia	NOUN
ajlm-2617	25	14	to	to	ADP
ajlm-2617	25	15	a	a	DET
ajlm-2617	25	16	regional	regional	ADJ
ajlm-2617	25	17	hospital	hospital	NOUN
ajlm-2617	25	18	in	in	ADP
ajlm-2617	25	19	north	north	PROPN
ajlm-2617	25	20	west	west	PROPN
ajlm-2617	25	21	province	province	PROPN
ajlm-2617	25	22	,	,	PUNCT
ajlm-2617	25	23	south	south	PROPN
ajlm-2617	25	24	africa	africa	PROPN
ajlm-2617	25	25	,	,	PUNCT
ajlm-2617	25	26	in	in	ADP
ajlm-2617	25	27	june	june	PROPN
ajlm-2617	25	28	2023	2023	NUM
ajlm-2617	25	29	.	.	PUNCT
ajlm-2617	26	1	on	on	ADP
ajlm-2617	26	2	clinical	clinical	ADJ
ajlm-2617	26	3	examination	examination	NOUN
ajlm-2617	26	4	,	,	PUNCT
ajlm-2617	26	5	she	she	PRON
ajlm-2617	26	6	had	have	VERB
ajlm-2617	26	7	massive	massive	ADJ
ajlm-2617	26	8	splenomegaly	splenomegaly	NOUN
ajlm-2617	26	9	but	but	CCONJ
ajlm-2617	26	10	no	no	DET
ajlm-2617	26	11	lymphadenopathy	lymphadenopathy	ADJ
ajlm-2617	26	12	.	.	PUNCT
ajlm-2617	27	1	an	an	DET
ajlm-2617	27	2	fbc	fbc	PROPN
ajlm-2617	27	3	was	be	AUX
ajlm-2617	27	4	performed	perform	VERB
ajlm-2617	27	5	on	on	ADP
ajlm-2617	27	6	a	a	DET
ajlm-2617	27	7	sysmex	sysmex	NOUN
ajlm-2617	27	8	xn-1000	xn-1000	PROPN
ajlm-2617	27	9	series	series	PROPN
ajlm-2617	27	10	and	and	CCONJ
ajlm-2617	27	11	showed	show	VERB
ajlm-2617	27	12	pancytopenia	pancytopenia	NOUN
ajlm-2617	27	13	(	(	PUNCT
ajlm-2617	27	14	haemoglobin	haemoglobin	NOUN
ajlm-2617	27	15	2.9	2.9	NUM
ajlm-2617	27	16	g	g	NOUN
ajlm-2617	27	17	/	/	SYM
ajlm-2617	27	18	dl	dl	PROPN
ajlm-2617	27	19	,	,	PUNCT
ajlm-2617	27	20	platelet	platelet	NOUN
ajlm-2617	27	21	count	count	VERB
ajlm-2617	27	22	97	97	NUM
ajlm-2617	27	23	l	l	NOUN
ajlm-2617	27	24	×	×	NOUN
ajlm-2617	27	25	109	109	NUM
ajlm-2617	27	26	/	/	SYM
ajlm-2617	27	27	l	l	NOUN
ajlm-2617	27	28	,	,	PUNCT
ajlm-2617	27	29	neutrophils	neutrophil	VERB
ajlm-2617	27	30	0.93	0.93	NUM
ajlm-2617	27	31	×	×	NOUN
ajlm-2617	27	32	109	109	NUM
ajlm-2617	27	33	/	/	SYM
ajlm-2617	27	34	l	l	NOUN
ajlm-2617	27	35	)	)	PUNCT
ajlm-2617	27	36	,	,	PUNCT
ajlm-2617	27	37	with	with	ADP
ajlm-2617	27	38	a	a	DET
ajlm-2617	27	39	leucocytosis	leucocytosis	NOUN
ajlm-2617	27	40	of	of	ADP
ajlm-2617	27	41	58	58	NUM
ajlm-2617	27	42	×	×	NOUN
ajlm-2617	27	43	109	109	NUM
ajlm-2617	27	44	/	/	SYM
ajlm-2617	27	45	l.	l.	PROPN
ajlm-2617	27	46	the	the	DET
ajlm-2617	27	47	automated	automate	VERB
ajlm-2617	27	48	wbc	wbc	PROPN
ajlm-2617	27	49	differential	differential	NOUN
ajlm-2617	27	50	count	count	NOUN
ajlm-2617	27	51	showed	show	VERB
ajlm-2617	27	52	a	a	DET
ajlm-2617	27	53	lymphocytosis	lymphocytosis	NOUN
ajlm-2617	27	54	of	of	ADP
ajlm-2617	27	55	14.16	14.16	NUM
ajlm-2617	27	56	×	×	NOUN
ajlm-2617	27	57	109	109	NUM
ajlm-2617	27	58	/	/	SYM
ajlm-2617	27	59	l	l	NOUN
ajlm-2617	27	60	and	and	CCONJ
ajlm-2617	27	61	a	a	DET
ajlm-2617	27	62	marked	mark	VERB
ajlm-2617	27	63	monocytosis	monocytosis	NOUN
ajlm-2617	27	64	of	of	ADP
ajlm-2617	27	65	42.82	42.82	NUM
ajlm-2617	27	66	×	×	NOUN
ajlm-2617	27	67	109	109	NUM
ajlm-2617	27	68	/	/	SYM
ajlm-2617	27	69	l.	l.	NOUN
ajlm-2617	27	70	the	the	DET
ajlm-2617	27	71	pb	pb	PROPN
ajlm-2617	27	72	smear	smear	NOUN
ajlm-2617	27	73	was	be	AUX
ajlm-2617	27	74	referred	refer	VERB
ajlm-2617	27	75	to	to	ADP
ajlm-2617	27	76	the	the	DET
ajlm-2617	27	77	nhls	nhls	PROPN
ajlm-2617	27	78	universitas	universita	NOUN
ajlm-2617	27	79	academic	academic	ADJ
ajlm-2617	27	80	laboratory	laboratory	NOUN
ajlm-2617	27	81	,	,	PUNCT
ajlm-2617	27	82	south	south	PROPN
ajlm-2617	27	83	africa	africa	PROPN
ajlm-2617	27	84	,	,	PUNCT
ajlm-2617	27	85	for	for	ADP
ajlm-2617	27	86	pathologist	pathologist	NOUN
ajlm-2617	27	87	review	review	NOUN
ajlm-2617	27	88	.	.	PUNCT
ajlm-2617	28	1	a	a	DET
ajlm-2617	28	2	manual	manual	ADJ
ajlm-2617	28	3	differential	differential	ADJ
ajlm-2617	28	4	count	count	NOUN
ajlm-2617	28	5	and	and	CCONJ
ajlm-2617	28	6	pb	pb	ADP
ajlm-2617	28	7	smear	smear	NOUN
ajlm-2617	28	8	microscopy	microscopy	NOUN
ajlm-2617	28	9	revealed	reveal	VERB
ajlm-2617	28	10	almost	almost	ADV
ajlm-2617	28	11	no	no	DET
ajlm-2617	28	12	monocytes	monocyte	NOUN
ajlm-2617	28	13	.	.	PUNCT
ajlm-2617	29	1	however	however	ADV
ajlm-2617	29	2	,	,	PUNCT
ajlm-2617	29	3	abnormal	abnormal	ADJ
ajlm-2617	29	4	lymphocytes	lymphocyte	NOUN
ajlm-2617	29	5	were	be	AUX
ajlm-2617	29	6	increased	increase	VERB
ajlm-2617	29	7	(	(	PUNCT
ajlm-2617	29	8	78	78	NUM
ajlm-2617	29	9	%	%	NOUN
ajlm-2617	29	10	)	)	PUNCT
ajlm-2617	29	11	(	(	PUNCT
ajlm-2617	29	12	figure	figure	NOUN
ajlm-2617	29	13	1	1	NUM
ajlm-2617	29	14	)	)	PUNCT
ajlm-2617	29	15	.	.	PUNCT
ajlm-2617	30	1	these	these	DET
ajlm-2617	30	2	cells	cell	NOUN
ajlm-2617	30	3	were	be	AUX
ajlm-2617	30	4	intermediate	intermediate	ADJ
ajlm-2617	30	5	in	in	ADP
ajlm-2617	30	6	size	size	NOUN
ajlm-2617	30	7	,	,	PUNCT
ajlm-2617	30	8	with	with	ADP
ajlm-2617	30	9	abundant	abundant	ADJ
ajlm-2617	30	10	pale	pale	ADJ
ajlm-2617	30	11	blue	blue	ADJ
ajlm-2617	30	12	cytoplasm	cytoplasm	ADJ
ajlm-2617	30	13	and	and	CCONJ
ajlm-2617	30	14	circumferential	circumferential	ADJ
ajlm-2617	30	15	villi	villi	NOUN
ajlm-2617	30	16	.	.	PUNCT
ajlm-2617	31	1	their	their	PRON
ajlm-2617	31	2	nuclei	nucleus	NOUN
ajlm-2617	31	3	were	be	AUX
ajlm-2617	31	4	kidney	kidney	NOUN
ajlm-2617	31	5	-	-	PUNCT
ajlm-2617	31	6	shaped	shape	VERB
ajlm-2617	31	7	with	with	ADP
ajlm-2617	31	8	a	a	DET
ajlm-2617	31	9	ground	ground	NOUN
ajlm-2617	31	10	-	-	PUNCT
ajlm-2617	31	11	glass	glass	NOUN
ajlm-2617	31	12	chromatin	chromatin	NOUN
ajlm-2617	31	13	pattern	pattern	NOUN
ajlm-2617	31	14	and	and	CCONJ
ajlm-2617	31	15	inconspicuous	inconspicuous	ADJ
ajlm-2617	31	16	nucleoli	nucleolus	NOUN
ajlm-2617	31	17	.	.	PUNCT
ajlm-2617	32	1	figure	figure	NOUN
ajlm-2617	32	2	1	1	NUM
ajlm-2617	32	3	:	:	PUNCT
ajlm-2617	32	4	(	(	PUNCT
ajlm-2617	32	5	a	a	X
ajlm-2617	32	6	–	–	PUNCT
ajlm-2617	32	7	d	d	NOUN
ajlm-2617	32	8	)	)	PUNCT
ajlm-2617	32	9	‘	'	PUNCT
ajlm-2617	32	10	hairy	hairy	ADJ
ajlm-2617	32	11	cells	cell	NOUN
ajlm-2617	32	12	’	'	PUNCT
ajlm-2617	32	13	on	on	ADP
ajlm-2617	32	14	the	the	DET
ajlm-2617	32	15	peripheral	peripheral	ADJ
ajlm-2617	32	16	blood	blood	NOUN
ajlm-2617	32	17	smear	smear	NOUN
ajlm-2617	32	18	of	of	ADP
ajlm-2617	32	19	a	a	DET
ajlm-2617	32	20	72	72	NUM
ajlm-2617	32	21	-	-	PUNCT
ajlm-2617	32	22	year	year	NOUN
ajlm-2617	32	23	-	-	PUNCT
ajlm-2617	32	24	old	old	ADJ
ajlm-2617	32	25	woman	woman	NOUN
ajlm-2617	32	26	diagnosed	diagnose	VERB
ajlm-2617	32	27	with	with	ADP
ajlm-2617	32	28	hairy	hairy	ADJ
ajlm-2617	32	29	cell	cell	NOUN
ajlm-2617	32	30	leukaemia	leukaemia	NOUN
ajlm-2617	32	31	at	at	ADP
ajlm-2617	32	32	national	national	PROPN
ajlm-2617	32	33	health	health	PROPN
ajlm-2617	32	34	laboratory	laboratory	PROPN
ajlm-2617	32	35	service	service	NOUN
ajlm-2617	32	36	universitas	universita	NOUN
ajlm-2617	32	37	academic	academic	ADJ
ajlm-2617	32	38	laboratory	laboratory	NOUN
ajlm-2617	32	39	,	,	PUNCT
ajlm-2617	32	40	south	south	PROPN
ajlm-2617	32	41	africa	africa	PROPN
ajlm-2617	32	42	,	,	PUNCT
ajlm-2617	32	43	in	in	ADP
ajlm-2617	32	44	june	june	PROPN
ajlm-2617	32	45	2023	2023	NUM
ajlm-2617	32	46	.	.	PUNCT
ajlm-2617	33	1	wright	wright	PROPN
ajlm-2617	33	2	’s	’s	PART
ajlm-2617	33	3	stain	stain	NOUN
ajlm-2617	33	4	(	(	PUNCT
ajlm-2617	33	5	a	a	X
ajlm-2617	33	6	)	)	PUNCT
ajlm-2617	33	7	50×	50×	NUM
ajlm-2617	33	8	objective	objective	NOUN
ajlm-2617	33	9	,	,	PUNCT
ajlm-2617	33	10	(	(	PUNCT
ajlm-2617	33	11	b	b	X
ajlm-2617	33	12	)	)	PUNCT
ajlm-2617	33	13	10×	10×	NOUN
ajlm-2617	33	14	objective	objective	NOUN
ajlm-2617	33	15	and	and	CCONJ
ajlm-2617	33	16	(	(	PUNCT
ajlm-2617	33	17	c	c	X
ajlm-2617	33	18	,	,	PUNCT
ajlm-2617	33	19	d	d	NOUN
ajlm-2617	33	20	)	)	PUNCT
ajlm-2617	33	21	100×	100×	PROPN
ajlm-2617	33	22	objective	objective	NOUN
ajlm-2617	33	23	.	.	PUNCT
ajlm-2617	34	1	(	(	PUNCT
ajlm-2617	34	2	e	e	NOUN
ajlm-2617	34	3	,	,	PUNCT
ajlm-2617	34	4	f	f	NOUN
ajlm-2617	34	5	)	)	PUNCT
ajlm-2617	34	6	for	for	ADP
ajlm-2617	34	7	comparison	comparison	NOUN
ajlm-2617	34	8	,	,	PUNCT
ajlm-2617	34	9	images	image	NOUN
ajlm-2617	34	10	of	of	ADP
ajlm-2617	34	11	normal	normal	ADJ
ajlm-2617	34	12	monocytes	monocyte	NOUN
ajlm-2617	34	13	on	on	ADP
ajlm-2617	34	14	a	a	DET
ajlm-2617	34	15	peripheral	peripheral	ADJ
ajlm-2617	34	16	smear	smear	NOUN
ajlm-2617	34	17	are	be	AUX
ajlm-2617	34	18	shown	show	VERB
ajlm-2617	34	19	;	;	PUNCT
ajlm-2617	34	20	wright	wright	PROPN
ajlm-2617	34	21	’s	’s	PART
ajlm-2617	34	22	stain	stain	NOUN
ajlm-2617	34	23	,	,	PUNCT
ajlm-2617	34	24	50×	50×	NOUN
ajlm-2617	34	25	objective	objective	NOUN
ajlm-2617	34	26	.	.	PUNCT
ajlm-2617	35	1	these	these	DET
ajlm-2617	35	2	cells	cell	NOUN
ajlm-2617	35	3	lack	lack	VERB
ajlm-2617	35	4	the	the	DET
ajlm-2617	35	5	circumferential	circumferential	ADJ
ajlm-2617	35	6	villi	villi	NOUN
ajlm-2617	35	7	and	and	CCONJ
ajlm-2617	35	8	ground	ground	NOUN
ajlm-2617	35	9	-	-	PUNCT
ajlm-2617	35	10	glass	glass	NOUN
ajlm-2617	35	11	chromatin	chromatin	NOUN
ajlm-2617	35	12	pattern	pattern	NOUN
ajlm-2617	35	13	of	of	ADP
ajlm-2617	35	14	‘	'	PUNCT
ajlm-2617	35	15	hairy	hairy	ADJ
ajlm-2617	35	16	cells	cell	NOUN
ajlm-2617	35	17	’	'	PUNCT
ajlm-2617	35	18	.	.	PUNCT
ajlm-2617	36	1	multiparameter	multiparameter	NOUN
ajlm-2617	36	2	flow	flow	NOUN
ajlm-2617	36	3	cytometry	cytometry	NOUN
ajlm-2617	36	4	was	be	AUX
ajlm-2617	36	5	performed	perform	VERB
ajlm-2617	36	6	on	on	ADP
ajlm-2617	36	7	the	the	DET
ajlm-2617	36	8	facscanto	facscanto	NOUN
ajlm-2617	36	9	™	™	PROPN
ajlm-2617	36	10	ii	ii	PROPN
ajlm-2617	36	11	(	(	PUNCT
ajlm-2617	36	12	becton	becton	PROPN
ajlm-2617	36	13	,	,	PUNCT
ajlm-2617	36	14	dickinson	dickinson	PROPN
ajlm-2617	36	15	,	,	PUNCT
ajlm-2617	36	16	and	and	CCONJ
ajlm-2617	36	17	company	company	NOUN
ajlm-2617	36	18	,	,	PUNCT
ajlm-2617	36	19	franklin	franklin	PROPN
ajlm-2617	36	20	lakes	lakes	PROPN
ajlm-2617	36	21	,	,	PUNCT
ajlm-2617	36	22	new	new	PROPN
ajlm-2617	36	23	jersey	jersey	PROPN
ajlm-2617	36	24	,	,	PUNCT
ajlm-2617	36	25	united	united	PROPN
ajlm-2617	36	26	states	states	PROPN
ajlm-2617	36	27	)	)	PUNCT
ajlm-2617	36	28	,	,	PUNCT
ajlm-2617	36	29	and	and	CCONJ
ajlm-2617	36	30	the	the	DET
ajlm-2617	36	31	data	datum	NOUN
ajlm-2617	36	32	analysed	analyse	VERB
ajlm-2617	36	33	on	on	ADP
ajlm-2617	36	34	infinicyt	infinicyt	PROPN
ajlm-2617	36	35	™	™	ADJ
ajlm-2617	36	36	version	version	NOUN
ajlm-2617	36	37	2.0	2.0	NUM
ajlm-2617	36	38	(	(	PUNCT
ajlm-2617	36	39	cytognos	cytogno	NOUN
ajlm-2617	36	40	,	,	PUNCT
ajlm-2617	36	41	santa	santa	PROPN
ajlm-2617	36	42	marta	marta	PROPN
ajlm-2617	36	43	de	de	PROPN
ajlm-2617	36	44	tormes	tormes	PROPN
ajlm-2617	36	45	,	,	PUNCT
ajlm-2617	36	46	salamanca	salamanca	PROPN
ajlm-2617	36	47	,	,	PUNCT
ajlm-2617	36	48	spain	spain	PROPN
ajlm-2617	36	49	)	)	PUNCT
ajlm-2617	36	50	software	software	NOUN
ajlm-2617	36	51	.	.	PUNCT
ajlm-2617	37	1	analysis	analysis	NOUN
ajlm-2617	37	2	revealed	reveal	VERB
ajlm-2617	37	3	an	an	DET
ajlm-2617	37	4	abnormal	abnormal	ADJ
ajlm-2617	37	5	population	population	NOUN
ajlm-2617	37	6	of	of	ADP
ajlm-2617	37	7	large	large	ADJ
ajlm-2617	37	8	cells	cell	NOUN
ajlm-2617	37	9	with	with	ADP
ajlm-2617	37	10	moderate	moderate	ADJ
ajlm-2617	37	11	complexity	complexity	NOUN
ajlm-2617	37	12	and	and	CCONJ
ajlm-2617	37	13	bright	bright	ADJ
ajlm-2617	37	14	cd45	cd45	PROPN
ajlm-2617	37	15	expression	expression	NOUN
ajlm-2617	37	16	extending	extend	VERB
ajlm-2617	37	17	into	into	ADP
ajlm-2617	37	18	the	the	DET
ajlm-2617	37	19	‘	'	PUNCT
ajlm-2617	37	20	monocyte	monocyte	NOUN
ajlm-2617	37	21	window	window	NOUN
ajlm-2617	37	22	’	'	PUNCT
ajlm-2617	37	23	(	(	PUNCT
ajlm-2617	37	24	figure	figure	NOUN
ajlm-2617	37	25	2	2	NUM
ajlm-2617	37	26	)	)	PUNCT
ajlm-2617	37	27	.	.	PUNCT
ajlm-2617	38	1	these	these	DET
ajlm-2617	38	2	cells	cell	NOUN
ajlm-2617	38	3	expressed	express	VERB
ajlm-2617	38	4	pan	pan	ADJ
ajlm-2617	38	5	-	-	ADJ
ajlm-2617	38	6	b	b	NOUN
ajlm-2617	38	7	-	-	PUNCT
ajlm-2617	38	8	cell	cell	NOUN
ajlm-2617	38	9	markers	marker	NOUN
ajlm-2617	38	10	,	,	PUNCT
ajlm-2617	38	11	cd19	cd19	PROPN
ajlm-2617	38	12	,	,	PUNCT
ajlm-2617	38	13	cd20	cd20	PROPN
ajlm-2617	38	14	,	,	PUNCT
ajlm-2617	38	15	cd22	cd22	PROPN
ajlm-2617	38	16	,	,	PUNCT
ajlm-2617	38	17	cd79b	cd79b	ADJ
ajlm-2617	38	18	,	,	PUNCT
ajlm-2617	38	19	and	and	CCONJ
ajlm-2617	38	20	sigm	sigm	NOUN
ajlm-2617	38	21	,	,	PUNCT
ajlm-2617	38	22	with	with	ADP
ajlm-2617	38	23	surface	surface	PROPN
ajlm-2617	38	24	kappa	kappa	PROPN
ajlm-2617	38	25	light	light	PROPN
ajlm-2617	38	26	chain	chain	NOUN
ajlm-2617	38	27	restriction	restriction	NOUN
ajlm-2617	38	28	.	.	PUNCT
ajlm-2617	39	1	villous	villous	ADJ
ajlm-2617	39	2	markers	marker	NOUN
ajlm-2617	39	3	(	(	PUNCT
ajlm-2617	39	4	cd11c	cd11c	NOUN
ajlm-2617	39	5	,	,	PUNCT
ajlm-2617	39	6	cd25	cd25	PROPN
ajlm-2617	39	7	,	,	PUNCT
ajlm-2617	39	8	cd103	cd103	NOUN
ajlm-2617	39	9	,	,	PUNCT
ajlm-2617	39	10	cd123	cd123	PROPN
ajlm-2617	39	11	)	)	PUNCT
ajlm-2617	39	12	and	and	CCONJ
ajlm-2617	39	13	cd200	cd200	PROPN
ajlm-2617	39	14	were	be	AUX
ajlm-2617	39	15	positive	positive	ADJ
ajlm-2617	39	16	.	.	PUNCT
ajlm-2617	40	1	this	this	DET
ajlm-2617	40	2	immunophenotype	immunophenotype	NOUN
ajlm-2617	40	3	is	be	AUX
ajlm-2617	40	4	characteristic	characteristic	ADJ
ajlm-2617	40	5	of	of	ADP
ajlm-2617	40	6	hcl.2,6	hcl.2,6	PROPN
ajlm-2617	40	7	there	there	PRON
ajlm-2617	40	8	was	be	VERB
ajlm-2617	40	9	no	no	DET
ajlm-2617	40	10	significant	significant	ADJ
ajlm-2617	40	11	monocyte	monocyte	NOUN
ajlm-2617	40	12	population	population	NOUN
ajlm-2617	40	13	.	.	PUNCT
ajlm-2617	41	1	figure	figure	NOUN
ajlm-2617	41	2	2	2	NUM
ajlm-2617	41	3	:	:	PUNCT
ajlm-2617	41	4	flow	flow	NOUN
ajlm-2617	41	5	cytometry	cytometry	NOUN
ajlm-2617	41	6	dot	dot	NOUN
ajlm-2617	41	7	plots	plot	NOUN
ajlm-2617	41	8	of	of	ADP
ajlm-2617	41	9	the	the	DET
ajlm-2617	41	10	pertinent	pertinent	ADJ
ajlm-2617	41	11	cluster	cluster	NOUN
ajlm-2617	41	12	of	of	ADP
ajlm-2617	41	13	differentiation	differentiation	NOUN
ajlm-2617	41	14	markers	marker	NOUN
ajlm-2617	41	15	used	use	VERB
ajlm-2617	41	16	in	in	ADP
ajlm-2617	41	17	the	the	DET
ajlm-2617	41	18	immunophenotypic	immunophenotypic	ADJ
ajlm-2617	41	19	diagnosis	diagnosis	NOUN
ajlm-2617	41	20	of	of	ADP
ajlm-2617	41	21	hairy	hairy	ADJ
ajlm-2617	41	22	cell	cell	NOUN
ajlm-2617	41	23	leukaemia	leukaemia	NOUN
ajlm-2617	41	24	that	that	PRON
ajlm-2617	41	25	were	be	AUX
ajlm-2617	41	26	performed	perform	VERB
ajlm-2617	41	27	for	for	ADP
ajlm-2617	41	28	our	our	PRON
ajlm-2617	41	29	patient	patient	NOUN
ajlm-2617	41	30	at	at	ADP
ajlm-2617	41	31	national	national	PROPN
ajlm-2617	41	32	health	health	PROPN
ajlm-2617	41	33	laboratory	laboratory	PROPN
ajlm-2617	41	34	service	service	NOUN
ajlm-2617	41	35	universitas	universita	NOUN
ajlm-2617	41	36	academic	academic	ADJ
ajlm-2617	41	37	laboratory	laboratory	NOUN
ajlm-2617	41	38	,	,	PUNCT
ajlm-2617	41	39	south	south	PROPN
ajlm-2617	41	40	africa	africa	PROPN
ajlm-2617	41	41	,	,	PUNCT
ajlm-2617	41	42	in	in	ADP
ajlm-2617	41	43	june	june	PROPN
ajlm-2617	41	44	2023	2023	NUM
ajlm-2617	41	45	.	.	PUNCT
ajlm-2617	42	1	the	the	DET
ajlm-2617	42	2	population	population	NOUN
ajlm-2617	42	3	of	of	ADP
ajlm-2617	42	4	interest	interest	NOUN
ajlm-2617	42	5	is	be	AUX
ajlm-2617	42	6	demonstrated	demonstrate	VERB
ajlm-2617	42	7	in	in	ADP
ajlm-2617	42	8	red	red	PROPN
ajlm-2617	42	9	.	.	PUNCT
ajlm-2617	43	1	the	the	DET
ajlm-2617	43	2	teal	teal	NOUN
ajlm-2617	43	3	green	green	ADJ
ajlm-2617	43	4	population	population	NOUN
ajlm-2617	43	5	represents	represent	VERB
ajlm-2617	43	6	normal	normal	ADJ
ajlm-2617	43	7	t	t	NOUN
ajlm-2617	43	8	cells	cell	NOUN
ajlm-2617	43	9	,	,	PUNCT
ajlm-2617	43	10	whilst	whilst	SCONJ
ajlm-2617	43	11	the	the	DET
ajlm-2617	43	12	pink	pink	ADJ
ajlm-2617	43	13	population	population	NOUN
ajlm-2617	43	14	constitutes	constitute	VERB
ajlm-2617	43	15	neutrophils	neutrophil	NOUN
ajlm-2617	43	16	,	,	PUNCT
ajlm-2617	43	17	and	and	CCONJ
ajlm-2617	43	18	the	the	DET
ajlm-2617	43	19	blue	blue	ADJ
ajlm-2617	43	20	population	population	NOUN
ajlm-2617	43	21	constitutes	constitute	VERB
ajlm-2617	43	22	natural	natural	ADJ
ajlm-2617	43	23	killer	killer	NOUN
ajlm-2617	43	24	cells	cell	NOUN
ajlm-2617	43	25	.	.	PUNCT
ajlm-2617	44	1	(	(	PUNCT
ajlm-2617	44	2	a	a	DET
ajlm-2617	44	3	,	,	PUNCT
ajlm-2617	44	4	b	b	NOUN
ajlm-2617	44	5	)	)	PUNCT
ajlm-2617	44	6	the	the	DET
ajlm-2617	44	7	hairy	hairy	ADJ
ajlm-2617	44	8	cells	cell	NOUN
ajlm-2617	44	9	are	be	AUX
ajlm-2617	44	10	large	large	ADJ
ajlm-2617	44	11	in	in	ADP
ajlm-2617	44	12	size	size	NOUN
ajlm-2617	44	13	(	(	PUNCT
ajlm-2617	44	14	increased	increase	VERB
ajlm-2617	44	15	fsc	fsc	PROPN
ajlm-2617	44	16	-	-	PUNCT
ajlm-2617	44	17	a	a	NOUN
ajlm-2617	44	18	)	)	PUNCT
ajlm-2617	44	19	with	with	ADP
ajlm-2617	44	20	bright	bright	ADJ
ajlm-2617	44	21	cd45	cd45	PROPN
ajlm-2617	44	22	expression	expression	NOUN
ajlm-2617	44	23	.	.	PUNCT
ajlm-2617	45	1	(	(	PUNCT
ajlm-2617	45	2	c	c	X
ajlm-2617	45	3	–	–	PUNCT
ajlm-2617	45	4	f	f	X
ajlm-2617	45	5	)	)	PUNCT
ajlm-2617	45	6	the	the	DET
ajlm-2617	45	7	hairy	hairy	ADJ
ajlm-2617	45	8	cells	cell	NOUN
ajlm-2617	45	9	brightly	brightly	ADV
ajlm-2617	45	10	express	express	VERB
ajlm-2617	45	11	pan	pan	ADJ
ajlm-2617	45	12	-	-	ADJ
ajlm-2617	45	13	b	b	NOUN
ajlm-2617	45	14	-	-	PUNCT
ajlm-2617	45	15	cell	cell	NOUN
ajlm-2617	45	16	markers	marker	NOUN
ajlm-2617	45	17	,	,	PUNCT
ajlm-2617	45	18	cd19	cd19	PROPN
ajlm-2617	45	19	,	,	PUNCT
ajlm-2617	45	20	cd20	cd20	PROPN
ajlm-2617	45	21	,	,	PUNCT
ajlm-2617	45	22	and	and	CCONJ
ajlm-2617	45	23	cd79b	cd79b	ADJ
ajlm-2617	45	24	,	,	PUNCT
ajlm-2617	45	25	with	with	ADP
ajlm-2617	45	26	surface	surface	NOUN
ajlm-2617	45	27	kappa	kappa	PROPN
ajlm-2617	45	28	light	light	PROPN
ajlm-2617	45	29	chain	chain	NOUN
ajlm-2617	45	30	restriction	restriction	NOUN
ajlm-2617	45	31	,	,	PUNCT
ajlm-2617	45	32	confirming	confirm	VERB
ajlm-2617	45	33	clonality	clonality	NOUN
ajlm-2617	45	34	.	.	PUNCT
ajlm-2617	46	1	(	(	PUNCT
ajlm-2617	46	2	g	g	NOUN
ajlm-2617	46	3	–	–	PUNCT
ajlm-2617	46	4	i	i	NOUN
ajlm-2617	46	5	)	)	PUNCT
ajlm-2617	46	6	the	the	DET
ajlm-2617	46	7	hairy	hairy	ADJ
ajlm-2617	46	8	cells	cell	NOUN
ajlm-2617	46	9	express	express	VERB
ajlm-2617	46	10	cd200	cd200	PROPN
ajlm-2617	46	11	with	with	ADP
ajlm-2617	46	12	co	co	NOUN
ajlm-2617	46	13	-	-	NOUN
ajlm-2617	46	14	expression	expression	NOUN
ajlm-2617	46	15	of	of	ADP
ajlm-2617	46	16	villous	villous	ADJ
ajlm-2617	46	17	markers	marker	NOUN
ajlm-2617	46	18	,	,	PUNCT
ajlm-2617	46	19	cd11c	cd11c	NOUN
ajlm-2617	46	20	,	,	PUNCT
ajlm-2617	46	21	cd25	cd25	PROPN
ajlm-2617	46	22	,	,	PUNCT
ajlm-2617	46	23	cd103	cd103	NOUN
ajlm-2617	46	24	,	,	PUNCT
ajlm-2617	46	25	and	and	CCONJ
ajlm-2617	46	26	cd123	cd123	PROPN
ajlm-2617	46	27	.	.	PUNCT
ajlm-2617	47	1	because	because	SCONJ
ajlm-2617	47	2	monocytopenia	monocytopenia	PROPN
ajlm-2617	47	3	,	,	PUNCT
ajlm-2617	47	4	rather	rather	ADV
ajlm-2617	47	5	than	than	ADP
ajlm-2617	47	6	monocytosis	monocytosis	NOUN
ajlm-2617	47	7	,	,	PUNCT
ajlm-2617	47	8	is	be	AUX
ajlm-2617	47	9	typically	typically	ADV
ajlm-2617	47	10	seen	see	VERB
ajlm-2617	47	11	in	in	ADP
ajlm-2617	47	12	hcl	hcl	PROPN
ajlm-2617	47	13	,	,	PUNCT
ajlm-2617	47	14	an	an	DET
ajlm-2617	47	15	fbc	fbc	PROPN
ajlm-2617	47	16	and	and	CCONJ
ajlm-2617	47	17	automated	automate	VERB
ajlm-2617	47	18	wbc	wbc	PROPN
ajlm-2617	47	19	differential	differential	NOUN
ajlm-2617	47	20	was	be	AUX
ajlm-2617	47	21	repeated	repeat	VERB
ajlm-2617	47	22	on	on	ADP
ajlm-2617	47	23	the	the	DET
ajlm-2617	47	24	advia	advia	PROPN
ajlm-2617	47	25	®	®	PROPN
ajlm-2617	47	26	2120i	2120i	PROPN
ajlm-2617	47	27	(	(	PUNCT
ajlm-2617	47	28	siemens	siemens	PROPN
ajlm-2617	47	29	healthineers	healthineer	NOUN
ajlm-2617	47	30	,	,	PUNCT
ajlm-2617	47	31	erlangen	erlangen	PROPN
ajlm-2617	47	32	,	,	PUNCT
ajlm-2617	47	33	germany	germany	PROPN
ajlm-2617	47	34	)	)	PUNCT
ajlm-2617	47	35	fbc	fbc	PROPN
ajlm-2617	47	36	analyser	analyser	NOUN
ajlm-2617	47	37	in	in	ADP
ajlm-2617	47	38	our	our	PRON
ajlm-2617	47	39	laboratory	laboratory	NOUN
ajlm-2617	47	40	.	.	PUNCT
ajlm-2617	48	1	the	the	DET
ajlm-2617	48	2	same	same	ADJ
ajlm-2617	48	3	blood	blood	NOUN
ajlm-2617	48	4	sample	sample	NOUN
ajlm-2617	48	5	subsequently	subsequently	ADV
ajlm-2617	48	6	revealed	reveal	VERB
ajlm-2617	48	7	a	a	DET
ajlm-2617	48	8	monocytopenia	monocytopenia	NOUN
ajlm-2617	48	9	of	of	ADP
ajlm-2617	48	10	0.93	0.93	NUM
ajlm-2617	48	11	×	×	NOUN
ajlm-2617	48	12	109	109	NUM
ajlm-2617	48	13	/	/	SYM
ajlm-2617	48	14	l	l	NOUN
ajlm-2617	48	15	,	,	PUNCT
ajlm-2617	48	16	with	with	ADP
ajlm-2617	48	17	an	an	DET
ajlm-2617	48	18	increase	increase	NOUN
ajlm-2617	48	19	in	in	ADP
ajlm-2617	48	20	the	the	DET
ajlm-2617	48	21	lymphocyte	lymphocyte	ADJ
ajlm-2617	48	22	count	count	NOUN
ajlm-2617	48	23	to	to	ADP
ajlm-2617	48	24	34.51	34.51	NUM
ajlm-2617	48	25	×	×	NOUN
ajlm-2617	48	26	109	109	NUM
ajlm-2617	48	27	/	/	SYM
ajlm-2617	48	28	l.	l.	NOUN
ajlm-2617	48	29	these	these	DET
ajlm-2617	48	30	counts	count	NOUN
ajlm-2617	48	31	correlated	correlate	VERB
ajlm-2617	48	32	with	with	ADP
ajlm-2617	48	33	the	the	DET
ajlm-2617	48	34	pathologist	pathologist	NOUN
ajlm-2617	48	35	’s	’s	PART
ajlm-2617	48	36	manual	manual	ADJ
ajlm-2617	48	37	differential	differential	ADJ
ajlm-2617	48	38	count	count	NOUN
ajlm-2617	48	39	and	and	CCONJ
ajlm-2617	48	40	flow	flow	VERB
ajlm-2617	48	41	cytometry	cytometry	ADJ
ajlm-2617	48	42	analysis	analysis	NOUN
ajlm-2617	48	43	.	.	PUNCT
ajlm-2617	49	1	it	it	PRON
ajlm-2617	49	2	was	be	AUX
ajlm-2617	49	3	concluded	conclude	VERB
ajlm-2617	49	4	that	that	SCONJ
ajlm-2617	49	5	the	the	DET
ajlm-2617	49	6	sysmex	sysmex	NOUN
ajlm-2617	49	7	xn-1000	xn-1000	PROPN
ajlm-2617	49	8	series	series	PROPN
ajlm-2617	49	9	spuriously	spuriously	ADV
ajlm-2617	49	10	counted	count	VERB
ajlm-2617	49	11	the	the	DET
ajlm-2617	49	12	‘	'	PUNCT
ajlm-2617	49	13	hairy	hairy	ADJ
ajlm-2617	49	14	cells	cell	NOUN
ajlm-2617	49	15	’	'	PUNCT
ajlm-2617	49	16	as	as	ADP
ajlm-2617	49	17	monocytes	monocyte	NOUN
ajlm-2617	49	18	,	,	PUNCT
ajlm-2617	49	19	resulting	result	VERB
ajlm-2617	49	20	in	in	ADP
ajlm-2617	49	21	pseudomonocytosis	pseudomonocytosis	NOUN
ajlm-2617	49	22	.	.	PUNCT
ajlm-2617	50	1	management	management	NOUN
ajlm-2617	50	2	and	and	CCONJ
ajlm-2617	50	3	outcomes	outcome	NOUN
ajlm-2617	50	4	the	the	DET
ajlm-2617	50	5	patient	patient	NOUN
ajlm-2617	50	6	was	be	AUX
ajlm-2617	50	7	referred	refer	VERB
ajlm-2617	50	8	to	to	ADP
ajlm-2617	50	9	a	a	DET
ajlm-2617	50	10	tertiary	tertiary	ADJ
ajlm-2617	50	11	hospital	hospital	NOUN
ajlm-2617	50	12	.	.	PUNCT
ajlm-2617	51	1	further	further	ADJ
ajlm-2617	51	2	workup	workup	NOUN
ajlm-2617	51	3	of	of	ADP
ajlm-2617	51	4	the	the	DET
ajlm-2617	51	5	case	case	NOUN
ajlm-2617	51	6	confirmed	confirm	VERB
ajlm-2617	51	7	a	a	DET
ajlm-2617	51	8	diagnosis	diagnosis	NOUN
ajlm-2617	51	9	of	of	ADP
ajlm-2617	51	10	hcl	hcl	PROPN
ajlm-2617	51	11	,	,	PUNCT
ajlm-2617	51	12	with	with	ADP
ajlm-2617	51	13	the	the	DET
ajlm-2617	51	14	detection	detection	NOUN
ajlm-2617	51	15	of	of	ADP
ajlm-2617	51	16	the	the	DET
ajlm-2617	51	17	brafv600e	brafv600e	ADJ
ajlm-2617	51	18	mutation	mutation	NOUN
ajlm-2617	51	19	and	and	CCONJ
ajlm-2617	51	20	characteristic	characteristic	ADJ
ajlm-2617	51	21	bm	bm	PROPN
ajlm-2617	51	22	morphology	morphology	PROPN
ajlm-2617	51	23	.	.	PUNCT
ajlm-2617	52	1	unfortunately	unfortunately	ADV
ajlm-2617	52	2	,	,	PUNCT
ajlm-2617	52	3	the	the	DET
ajlm-2617	52	4	patient	patient	NOUN
ajlm-2617	52	5	demised	demise	VERB
ajlm-2617	52	6	shortly	shortly	ADV
ajlm-2617	52	7	after	after	ADP
ajlm-2617	52	8	admission	admission	NOUN
ajlm-2617	52	9	,	,	PUNCT
ajlm-2617	52	10	and	and	CCONJ
ajlm-2617	52	11	further	further	ADJ
ajlm-2617	52	12	details	detail	NOUN
ajlm-2617	52	13	regarding	regard	VERB
ajlm-2617	52	14	treatment	treatment	NOUN
ajlm-2617	52	15	could	could	AUX
ajlm-2617	52	16	not	not	PART
ajlm-2617	52	17	be	be	AUX
ajlm-2617	52	18	obtained	obtain	VERB
ajlm-2617	52	19	.	.	PUNCT
ajlm-2617	53	1	discussion	discussion	NOUN
ajlm-2617	53	2	monocytopenia	monocytopenia	NOUN
ajlm-2617	53	3	in	in	ADP
ajlm-2617	53	4	the	the	DET
ajlm-2617	53	5	setting	setting	NOUN
ajlm-2617	53	6	of	of	ADP
ajlm-2617	53	7	pancytopenia	pancytopenia	NOUN
ajlm-2617	53	8	should	should	AUX
ajlm-2617	53	9	trigger	trigger	VERB
ajlm-2617	53	10	a	a	DET
ajlm-2617	53	11	suspicion	suspicion	NOUN
ajlm-2617	53	12	of	of	ADP
ajlm-2617	53	13	hcl.3,4	hcl.3,4	ADJ
ajlm-2617	53	14	demonstrating	demonstrate	VERB
ajlm-2617	53	15	clonal	clonal	ADJ
ajlm-2617	53	16	b	b	PROPN
ajlm-2617	53	17	cells	cell	NOUN
ajlm-2617	53	18	with	with	ADP
ajlm-2617	53	19	‘	'	PUNCT
ajlm-2617	53	20	villous	villous	ADJ
ajlm-2617	53	21	’	'	PUNCT
ajlm-2617	53	22	markers	marker	NOUN
ajlm-2617	53	23	(	(	PUNCT
ajlm-2617	53	24	cd11c	cd11c	NOUN
ajlm-2617	53	25	,	,	PUNCT
ajlm-2617	53	26	cd25	cd25	PROPN
ajlm-2617	53	27	,	,	PUNCT
ajlm-2617	53	28	cd103	cd103	NOUN
ajlm-2617	53	29	,	,	PUNCT
ajlm-2617	53	30	and	and	CCONJ
ajlm-2617	53	31	cd123	cd123	PROPN
ajlm-2617	53	32	)	)	PUNCT
ajlm-2617	53	33	on	on	ADP
ajlm-2617	53	34	multiparameter	multiparameter	NOUN
ajlm-2617	53	35	flow	flow	NOUN
ajlm-2617	53	36	cytometry	cytometry	NOUN
ajlm-2617	53	37	is	be	AUX
ajlm-2617	53	38	critical	critical	ADJ
ajlm-2617	53	39	for	for	ADP
ajlm-2617	53	40	the	the	DET
ajlm-2617	53	41	timely	timely	ADJ
ajlm-2617	53	42	diagnosis	diagnosis	NOUN
ajlm-2617	53	43	of	of	ADP
ajlm-2617	53	44	hcl.2,6,10	hcl.2,6,10	NOUN
ajlm-2617	53	45	however	however	ADV
ajlm-2617	53	46	,	,	PUNCT
ajlm-2617	53	47	characteristic	characteristic	ADJ
ajlm-2617	53	48	lymphocytes	lymphocyte	VERB
ajlm-2617	53	49	with	with	ADP
ajlm-2617	53	50	circumferential	circumferential	ADJ
ajlm-2617	53	51	villi	villi	NOUN
ajlm-2617	53	52	(	(	PUNCT
ajlm-2617	53	53	‘	'	PUNCT
ajlm-2617	53	54	hairy	hairy	ADJ
ajlm-2617	53	55	cells	cell	NOUN
ajlm-2617	53	56	’	'	PUNCT
ajlm-2617	53	57	)	)	PUNCT
ajlm-2617	53	58	may	may	AUX
ajlm-2617	53	59	be	be	AUX
ajlm-2617	53	60	sparse	sparse	ADJ
ajlm-2617	53	61	on	on	ADP
ajlm-2617	53	62	pb	pb	ADP
ajlm-2617	53	63	morphology.1,10	morphology.1,10	NOUN
ajlm-2617	53	64	unless	unless	SCONJ
ajlm-2617	53	65	the	the	DET
ajlm-2617	53	66	pathologist	pathologist	NOUN
ajlm-2617	53	67	has	have	VERB
ajlm-2617	53	68	a	a	DET
ajlm-2617	53	69	high	high	ADJ
ajlm-2617	53	70	index	index	NOUN
ajlm-2617	53	71	of	of	ADP
ajlm-2617	53	72	suspicion	suspicion	NOUN
ajlm-2617	53	73	on	on	ADP
ajlm-2617	53	74	the	the	DET
ajlm-2617	53	75	initial	initial	NOUN
ajlm-2617	53	76	pb	pb	ADP
ajlm-2617	53	77	smear	smear	NOUN
ajlm-2617	53	78	review	review	PROPN
ajlm-2617	53	79	,	,	PUNCT
ajlm-2617	53	80	the	the	DET
ajlm-2617	53	81	diagnosis	diagnosis	NOUN
ajlm-2617	53	82	of	of	ADP
ajlm-2617	53	83	hcl	hcl	PROPN
ajlm-2617	53	84	may	may	AUX
ajlm-2617	53	85	be	be	AUX
ajlm-2617	53	86	unnecessarily	unnecessarily	ADV
ajlm-2617	53	87	delayed	delay	VERB
ajlm-2617	53	88	until	until	SCONJ
ajlm-2617	53	89	a	a	PRON
ajlm-2617	53	90	bm	bm	PROPN
ajlm-2617	53	91	aspirate	aspirate	NOUN
ajlm-2617	53	92	and	and	CCONJ
ajlm-2617	53	93	trephine	trephine	ADJ
ajlm-2617	53	94	biopsy	biopsy	NOUN
ajlm-2617	53	95	and	and	CCONJ
ajlm-2617	53	96	molecular	molecular	ADJ
ajlm-2617	53	97	studies	study	NOUN
ajlm-2617	53	98	for	for	ADP
ajlm-2617	53	99	the	the	DET
ajlm-2617	53	100	brafv600e	brafv600e	ADJ
ajlm-2617	53	101	mutation	mutation	NOUN
ajlm-2617	53	102	are	be	AUX
ajlm-2617	53	103	performed	perform	VERB
ajlm-2617	53	104	.	.	PUNCT
ajlm-2617	54	1	furthermore	furthermore	ADV
ajlm-2617	54	2	,	,	PUNCT
ajlm-2617	54	3	bm	bm	PROPN
ajlm-2617	54	4	aspiration	aspiration	NOUN
ajlm-2617	54	5	is	be	AUX
ajlm-2617	54	6	frequently	frequently	ADV
ajlm-2617	54	7	unsuccessful	unsuccessful	ADJ
ajlm-2617	54	8	because	because	SCONJ
ajlm-2617	54	9	of	of	ADP
ajlm-2617	54	10	bm	bm	PROPN
ajlm-2617	54	11	fibrosis	fibrosis	NOUN
ajlm-2617	54	12	in	in	ADP
ajlm-2617	54	13	hcl.2,10	hcl.2,10	NOUN
ajlm-2617	54	14	it	it	PRON
ajlm-2617	54	15	is	be	AUX
ajlm-2617	54	16	important	important	ADJ
ajlm-2617	54	17	to	to	PART
ajlm-2617	54	18	note	note	VERB
ajlm-2617	54	19	that	that	SCONJ
ajlm-2617	54	20	the	the	DET
ajlm-2617	54	21	leucocytosis	leucocytosis	NOUN
ajlm-2617	54	22	and	and	CCONJ
ajlm-2617	54	23	abundance	abundance	NOUN
ajlm-2617	54	24	of	of	ADP
ajlm-2617	54	25	‘	'	PUNCT
ajlm-2617	54	26	hairy	hairy	ADJ
ajlm-2617	54	27	cells	cell	NOUN
ajlm-2617	54	28	’	'	PUNCT
ajlm-2617	54	29	(	(	PUNCT
ajlm-2617	54	30	78	78	NUM
ajlm-2617	54	31	%	%	NOUN
ajlm-2617	54	32	)	)	PUNCT
ajlm-2617	54	33	that	that	PRON
ajlm-2617	54	34	were	be	AUX
ajlm-2617	54	35	seen	see	VERB
ajlm-2617	54	36	in	in	ADP
ajlm-2617	54	37	our	our	PRON
ajlm-2617	54	38	case	case	NOUN
ajlm-2617	54	39	is	be	AUX
ajlm-2617	54	40	unusual	unusual	ADJ
ajlm-2617	54	41	.	.	PUNCT
ajlm-2617	55	1	lymphocytosis	lymphocytosis	PROPN
ajlm-2617	55	2	is	be	AUX
ajlm-2617	55	3	only	only	ADV
ajlm-2617	55	4	reported	report	VERB
ajlm-2617	55	5	in	in	ADP
ajlm-2617	55	6	5	5	NUM
ajlm-2617	55	7	%	%	NOUN
ajlm-2617	55	8	–	–	PUNCT
ajlm-2617	55	9	10	10	NUM
ajlm-2617	55	10	%	%	NOUN
ajlm-2617	55	11	of	of	ADP
ajlm-2617	55	12	cases	case	NOUN
ajlm-2617	55	13	of	of	ADP
ajlm-2617	55	14	hcl.1	hcl.1	VERB
ajlm-2617	55	15	by	by	ADP
ajlm-2617	55	16	comparison	comparison	NOUN
ajlm-2617	55	17	,	,	PUNCT
ajlm-2617	55	18	the	the	DET
ajlm-2617	55	19	hcl	hcl	PROPN
ajlm-2617	55	20	cases	case	NOUN
ajlm-2617	55	21	evaluated	evaluate	VERB
ajlm-2617	55	22	by	by	ADP
ajlm-2617	55	23	tofan	tofan	NOUN
ajlm-2617	55	24	et	et	NOUN
ajlm-2617	55	25	al.3	al.3	PROPN
ajlm-2617	55	26	and	and	CCONJ
ajlm-2617	55	27	furundarena	furundarena	NOUN
ajlm-2617	55	28	et	et	PROPN
ajlm-2617	55	29	al.11	al.11	PROPN
ajlm-2617	55	30	revealed	reveal	VERB
ajlm-2617	55	31	an	an	DET
ajlm-2617	55	32	average	average	NOUN
ajlm-2617	55	33	of	of	ADP
ajlm-2617	55	34	19.6	19.6	NUM
ajlm-2617	55	35	%	%	NOUN
ajlm-2617	55	36	and	and	CCONJ
ajlm-2617	55	37	9.4	9.4	NUM
ajlm-2617	55	38	%	%	NOUN
ajlm-2617	55	39	circulating	circulate	VERB
ajlm-2617	55	40	‘	'	PUNCT
ajlm-2617	55	41	hairy	hairy	ADJ
ajlm-2617	55	42	cells	cell	NOUN
ajlm-2617	55	43	’	'	PUNCT
ajlm-2617	55	44	.	.	PUNCT
ajlm-2617	56	1	villous	villous	ADJ
ajlm-2617	56	2	lymphocytes	lymphocyte	NOUN
ajlm-2617	56	3	are	be	AUX
ajlm-2617	56	4	not	not	PART
ajlm-2617	56	5	unique	unique	ADJ
ajlm-2617	56	6	to	to	ADP
ajlm-2617	56	7	hcl	hcl	PROPN
ajlm-2617	56	8	.	.	PUNCT
ajlm-2617	57	1	their	their	PRON
ajlm-2617	57	2	differential	differential	ADJ
ajlm-2617	57	3	diagnosis	diagnosis	NOUN
ajlm-2617	57	4	includes	include	VERB
ajlm-2617	57	5	artefact	artefact	NOUN
ajlm-2617	57	6	and	and	CCONJ
ajlm-2617	57	7	other	other	ADJ
ajlm-2617	57	8	splenic	splenic	PROPN
ajlm-2617	57	9	b	b	PROPN
ajlm-2617	57	10	-	-	PUNCT
ajlm-2617	57	11	cell	cell	NOUN
ajlm-2617	57	12	lymphomas	lymphoma	NOUN
ajlm-2617	57	13	/	/	SYM
ajlm-2617	57	14	leukaemias	leukaemia	NOUN
ajlm-2617	57	15	,	,	PUNCT
ajlm-2617	57	16	namely	namely	ADV
ajlm-2617	57	17	splenic	splenic	ADJ
ajlm-2617	57	18	diffuse	diffuse	ADJ
ajlm-2617	57	19	red	red	ADJ
ajlm-2617	57	20	pulp	pulp	NOUN
ajlm-2617	57	21	lymphoma	lymphoma	NOUN
ajlm-2617	57	22	,	,	PUNCT
ajlm-2617	57	23	splenic	splenic	ADJ
ajlm-2617	57	24	marginal	marginal	ADJ
ajlm-2617	57	25	zone	zone	NOUN
ajlm-2617	57	26	lymphoma	lymphoma	NOUN
ajlm-2617	57	27	and	and	CCONJ
ajlm-2617	57	28	hcl	hcl	PROPN
ajlm-2617	57	29	variant	variant	NOUN
ajlm-2617	57	30	(	(	PUNCT
ajlm-2617	57	31	an	an	DET
ajlm-2617	57	32	entity	entity	NOUN
ajlm-2617	57	33	retained	retain	VERB
ajlm-2617	57	34	in	in	ADP
ajlm-2617	57	35	the	the	DET
ajlm-2617	57	36	international	international	ADJ
ajlm-2617	57	37	consensus	consensus	NOUN
ajlm-2617	57	38	classification	classification	NOUN
ajlm-2617	57	39	,	,	PUNCT
ajlm-2617	57	40	but	but	CCONJ
ajlm-2617	57	41	reclassified	reclassify	VERB
ajlm-2617	57	42	as	as	ADP
ajlm-2617	57	43	splenic	splenic	ADJ
ajlm-2617	57	44	b	b	NOUN
ajlm-2617	57	45	-	-	PUNCT
ajlm-2617	57	46	cell	cell	NOUN
ajlm-2617	57	47	lymphoma	lymphoma	NOUN
ajlm-2617	57	48	/	/	SYM
ajlm-2617	57	49	leukaemia	leukaemia	NOUN
ajlm-2617	57	50	with	with	ADP
ajlm-2617	57	51	prominent	prominent	ADJ
ajlm-2617	57	52	nucleoli	nucleolus	NOUN
ajlm-2617	57	53	in	in	ADP
ajlm-2617	57	54	the	the	DET
ajlm-2617	57	55	world	world	NOUN
ajlm-2617	57	56	health	health	NOUN
ajlm-2617	57	57	organization	organization	NOUN
ajlm-2617	57	58	classification	classification	NOUN
ajlm-2617	57	59	of	of	ADP
ajlm-2617	57	60	haematolymphoid	haematolymphoid	ADJ
ajlm-2617	57	61	tumours	tumours	NOUN
ajlm-2617	57	62	5th	5th	ADJ
ajlm-2617	57	63	edition).12	edition).12	ADP
ajlm-2617	57	64	considering	consider	VERB
ajlm-2617	57	65	its	its	PRON
ajlm-2617	57	66	relative	relative	ADJ
ajlm-2617	57	67	sensitivity	sensitivity	NOUN
ajlm-2617	57	68	and	and	CCONJ
ajlm-2617	57	69	specificity	specificity	NOUN
ajlm-2617	57	70	for	for	ADP
ajlm-2617	57	71	hcl	hcl	PROPN
ajlm-2617	57	72	,	,	PUNCT
ajlm-2617	57	73	the	the	DET
ajlm-2617	57	74	presence	presence	NOUN
ajlm-2617	57	75	or	or	CCONJ
ajlm-2617	57	76	absence	absence	NOUN
ajlm-2617	57	77	of	of	ADP
ajlm-2617	57	78	monocytopenia	monocytopenia	NOUN
ajlm-2617	57	79	is	be	AUX
ajlm-2617	57	80	often	often	ADV
ajlm-2617	57	81	relied	rely	VERB
ajlm-2617	57	82	on	on	ADP
ajlm-2617	57	83	during	during	ADP
ajlm-2617	57	84	the	the	DET
ajlm-2617	57	85	initial	initial	ADJ
ajlm-2617	57	86	assessment	assessment	NOUN
ajlm-2617	57	87	of	of	ADP
ajlm-2617	57	88	these	these	DET
ajlm-2617	57	89	lymphomas	lymphoma	NOUN
ajlm-2617	57	90	to	to	PART
ajlm-2617	57	91	assist	assist	VERB
ajlm-2617	57	92	with	with	ADP
ajlm-2617	57	93	the	the	DET
ajlm-2617	57	94	differential	differential	ADJ
ajlm-2617	57	95	diagnosis.3,10	diagnosis.3,10	NOUN
ajlm-2617	57	96	however	however	ADV
ajlm-2617	57	97	,	,	PUNCT
ajlm-2617	57	98	the	the	DET
ajlm-2617	57	99	sensitivity	sensitivity	NOUN
ajlm-2617	57	100	for	for	ADP
ajlm-2617	57	101	detecting	detect	VERB
ajlm-2617	57	102	monocytopenia	monocytopenia	NOUN
ajlm-2617	57	103	in	in	ADP
ajlm-2617	57	104	hcl	hcl	PROPN
ajlm-2617	57	105	varies	vary	VERB
ajlm-2617	57	106	amongst	amongst	ADP
ajlm-2617	57	107	automated	automate	VERB
ajlm-2617	57	108	fbc	fbc	PROPN
ajlm-2617	57	109	haematology	haematology	NOUN
ajlm-2617	57	110	analysers	analyser	NOUN
ajlm-2617	57	111	,	,	PUNCT
ajlm-2617	57	112	and	and	CCONJ
ajlm-2617	57	113	may	may	AUX
ajlm-2617	57	114	be	be	AUX
ajlm-2617	57	115	more	more	ADV
ajlm-2617	57	116	reliable	reliable	ADJ
ajlm-2617	57	117	on	on	ADP
ajlm-2617	57	118	instruments	instrument	NOUN
ajlm-2617	57	119	using	use	VERB
ajlm-2617	57	120	peroxidase	peroxidase	NOUN
ajlm-2617	57	121	staining	stain	VERB
ajlm-2617	57	122	techniques	technique	NOUN
ajlm-2617	57	123	such	such	ADJ
ajlm-2617	57	124	as	as	ADP
ajlm-2617	57	125	the	the	DET
ajlm-2617	57	126	advia	advia	NOUN
ajlm-2617	57	127	®	®	NOUN
ajlm-2617	57	128	2120i.4	2120i.4	PROPN
ajlm-2617	57	129	instruments	instrument	VERB
ajlm-2617	57	130	utilising	utilise	VERB
ajlm-2617	57	131	fluorescent	fluorescent	NOUN
ajlm-2617	57	132	staining	stain	VERB
ajlm-2617	57	133	and	and	CCONJ
ajlm-2617	57	134	light	light	NOUN
ajlm-2617	57	135	scatter	scatter	NOUN
ajlm-2617	57	136	,	,	PUNCT
ajlm-2617	57	137	or	or	CCONJ
ajlm-2617	57	138	physical	physical	ADJ
ajlm-2617	57	139	properties	property	NOUN
ajlm-2617	57	140	of	of	ADP
ajlm-2617	57	141	cells	cell	NOUN
ajlm-2617	57	142	,	,	PUNCT
ajlm-2617	57	143	may	may	AUX
ajlm-2617	57	144	yield	yield	VERB
ajlm-2617	57	145	inaccurate	inaccurate	ADJ
ajlm-2617	57	146	monocyte	monocyte	NOUN
ajlm-2617	57	147	counts	count	NOUN
ajlm-2617	57	148	in	in	ADP
ajlm-2617	57	149	hcl.3,4	hcl.3,4	ADJ
ajlm-2617	57	150	sysmex	sysmex	NOUN
ajlm-2617	57	151	xn	xn	NOUN
ajlm-2617	57	152	-	-	PUNCT
ajlm-2617	57	153	series	series	NOUN
ajlm-2617	57	154	automated	automate	VERB
ajlm-2617	57	155	fbc	fbc	PROPN
ajlm-2617	57	156	haematology	haematology	NOUN
ajlm-2617	57	157	analysers	analyser	NOUN
ajlm-2617	57	158	incorporate	incorporate	VERB
ajlm-2617	57	159	cytochemical	cytochemical	ADJ
ajlm-2617	57	160	reactions	reaction	NOUN
ajlm-2617	57	161	followed	follow	VERB
ajlm-2617	57	162	by	by	ADP
ajlm-2617	57	163	fluorescence	fluorescence	NOUN
ajlm-2617	57	164	flow	flow	NOUN
ajlm-2617	57	165	cytometry	cytometry	NOUN
ajlm-2617	57	166	using	use	VERB
ajlm-2617	57	167	a	a	DET
ajlm-2617	57	168	semiconductor	semiconductor	NOUN
ajlm-2617	57	169	laser	laser	NOUN
ajlm-2617	57	170	to	to	PART
ajlm-2617	57	171	perform	perform	VERB
ajlm-2617	57	172	a	a	DET
ajlm-2617	57	173	wbc	wbc	PROPN
ajlm-2617	57	174	differential	differential	ADJ
ajlm-2617	57	175	count	count	NOUN
ajlm-2617	57	176	.	.	PUNCT
ajlm-2617	58	1	this	this	DET
ajlm-2617	58	2	method	method	NOUN
ajlm-2617	58	3	involves	involve	VERB
ajlm-2617	58	4	the	the	DET
ajlm-2617	58	5	addition	addition	NOUN
ajlm-2617	58	6	of	of	ADP
ajlm-2617	58	7	a	a	DET
ajlm-2617	58	8	fluorescent	fluorescent	ADJ
ajlm-2617	58	9	dye	dye	NOUN
ajlm-2617	58	10	to	to	AUX
ajlm-2617	58	11	wbcs	wbc	NOUN
ajlm-2617	58	12	,	,	PUNCT
ajlm-2617	58	13	which	which	PRON
ajlm-2617	58	14	are	be	AUX
ajlm-2617	58	15	subsequently	subsequently	ADV
ajlm-2617	58	16	separated	separate	VERB
ajlm-2617	58	17	by	by	ADP
ajlm-2617	58	18	their	their	PRON
ajlm-2617	58	19	different	different	ADJ
ajlm-2617	58	20	light	light	NOUN
ajlm-2617	58	21	scatter	scatter	NOUN
ajlm-2617	58	22	properties	property	NOUN
ajlm-2617	58	23	according	accord	VERB
ajlm-2617	58	24	to	to	ADP
ajlm-2617	58	25	size	size	NOUN
ajlm-2617	58	26	(	(	PUNCT
ajlm-2617	58	27	forward	forward	ADV
ajlm-2617	58	28	scatter	scatter	NOUN
ajlm-2617	58	29	)	)	PUNCT
ajlm-2617	58	30	,	,	PUNCT
ajlm-2617	58	31	complexity	complexity	NOUN
ajlm-2617	58	32	(	(	PUNCT
ajlm-2617	58	33	side	side	NOUN
ajlm-2617	58	34	scatter	scatter	NOUN
ajlm-2617	58	35	)	)	PUNCT
ajlm-2617	58	36	,	,	PUNCT
ajlm-2617	58	37	and	and	CCONJ
ajlm-2617	58	38	fluorescence	fluorescence	NOUN
ajlm-2617	58	39	signal.3,13,14	signal.3,13,14	ADV
ajlm-2617	58	40	scattergrams	scattergram	NOUN
ajlm-2617	58	41	provide	provide	VERB
ajlm-2617	58	42	a	a	DET
ajlm-2617	58	43	visual	visual	ADJ
ajlm-2617	58	44	representation	representation	NOUN
ajlm-2617	58	45	of	of	ADP
ajlm-2617	58	46	separated	separate	VERB
ajlm-2617	58	47	cell	cell	NOUN
ajlm-2617	58	48	population	population	NOUN
ajlm-2617	58	49	in	in	ADP
ajlm-2617	58	50	the	the	DET
ajlm-2617	58	51	white	white	ADJ
ajlm-2617	58	52	cell	cell	NOUN
ajlm-2617	58	53	nucleated-	nucleated-	NOUN
ajlm-2617	58	54	,	,	PUNCT
ajlm-2617	58	55	white	white	ADJ
ajlm-2617	58	56	cell	cell	NOUN
ajlm-2617	58	57	differential-	differential-	NOUN
ajlm-2617	58	58	,	,	PUNCT
ajlm-2617	58	59	and	and	CCONJ
ajlm-2617	58	60	white	white	ADJ
ajlm-2617	58	61	cell	cell	NOUN
ajlm-2617	58	62	precursor	precursor	NOUN
ajlm-2617	58	63	channels.3,13	channels.3,13	VERB
ajlm-2617	58	64	additionally	additionally	ADV
ajlm-2617	58	65	,	,	PUNCT
ajlm-2617	58	66	internal	internal	ADJ
ajlm-2617	58	67	protocol	protocol	NOUN
ajlm-2617	58	68	messages	message	NOUN
ajlm-2617	58	69	or	or	CCONJ
ajlm-2617	58	70	‘	'	PUNCT
ajlm-2617	58	71	flags	flag	NOUN
ajlm-2617	58	72	’	'	PUNCT
ajlm-2617	58	73	assist	assist	NOUN
ajlm-2617	58	74	with	with	ADP
ajlm-2617	58	75	the	the	DET
ajlm-2617	58	76	rapid	rapid	ADJ
ajlm-2617	58	77	identification	identification	NOUN
ajlm-2617	58	78	of	of	ADP
ajlm-2617	58	79	quantitative	quantitative	ADJ
ajlm-2617	58	80	and	and	CCONJ
ajlm-2617	58	81	qualitative	qualitative	ADJ
ajlm-2617	58	82	wbc	wbc	PROPN
ajlm-2617	58	83	abnormalities.8,9	abnormalities.8,9	PROPN
ajlm-2617	58	84	in	in	ADP
ajlm-2617	58	85	our	our	PRON
ajlm-2617	58	86	case	case	NOUN
ajlm-2617	58	87	,	,	PUNCT
ajlm-2617	58	88	the	the	DET
ajlm-2617	58	89	sysmex	sysmex	NOUN
ajlm-2617	58	90	xn-1000	xn-1000	PROPN
ajlm-2617	58	91	series	series	PROPN
ajlm-2617	58	92	correctly	correctly	ADV
ajlm-2617	58	93	flagged	flag	VERB
ajlm-2617	58	94	‘	'	PUNCT
ajlm-2617	58	95	neutropenia	neutropenia	NOUN
ajlm-2617	58	96	’	'	PUNCT
ajlm-2617	58	97	,	,	PUNCT
ajlm-2617	58	98	‘	'	PUNCT
ajlm-2617	58	99	leucocytosis	leucocytosis	NOUN
ajlm-2617	58	100	’	'	PUNCT
ajlm-2617	58	101	,	,	PUNCT
ajlm-2617	58	102	‘	'	PUNCT
ajlm-2617	58	103	lymphocytosis	lymphocytosis	NOUN
ajlm-2617	58	104	’	'	PUNCT
ajlm-2617	58	105	and	and	CCONJ
ajlm-2617	58	106	the	the	DET
ajlm-2617	58	107	presence	presence	NOUN
ajlm-2617	58	108	of	of	ADP
ajlm-2617	58	109	‘	'	PUNCT
ajlm-2617	58	110	blasts	blast	NOUN
ajlm-2617	58	111	/	/	SYM
ajlm-2617	58	112	abn	abn	NOUN
ajlm-2617	58	113	lymphocytes	lymphocyte	VERB
ajlm-2617	58	114	?	?	PUNCT
ajlm-2617	58	115	’	'	PUNCT
ajlm-2617	59	1	(	(	PUNCT
ajlm-2617	59	2	sic	sic	ADJ
ajlm-2617	59	3	)	)	PUNCT
ajlm-2617	59	4	.	.	PUNCT
ajlm-2617	60	1	the	the	DET
ajlm-2617	60	2	white	white	PROPN
ajlm-2617	60	3	cell	cell	PROPN
ajlm-2617	60	4	differential	differential	PROPN
ajlm-2617	60	5	scattergram	scattergram	PROPN
ajlm-2617	60	6	showed	show	VERB
ajlm-2617	60	7	a	a	DET
ajlm-2617	60	8	large	large	ADJ
ajlm-2617	60	9	population	population	NOUN
ajlm-2617	60	10	of	of	ADP
ajlm-2617	60	11	cells	cell	NOUN
ajlm-2617	60	12	in	in	ADP
ajlm-2617	60	13	the	the	DET
ajlm-2617	60	14	‘	'	PUNCT
ajlm-2617	60	15	monocyte	monocyte	NOUN
ajlm-2617	60	16	window	window	NOUN
ajlm-2617	60	17	’	'	PUNCT
ajlm-2617	60	18	(	(	PUNCT
ajlm-2617	60	19	figure	figure	NOUN
ajlm-2617	60	20	3	3	NUM
ajlm-2617	60	21	)	)	PUNCT
ajlm-2617	60	22	.	.	PUNCT
ajlm-2617	61	1	based	base	VERB
ajlm-2617	61	2	on	on	ADP
ajlm-2617	61	3	their	their	PRON
ajlm-2617	61	4	similar	similar	ADJ
ajlm-2617	61	5	forward	forward	NOUN
ajlm-2617	61	6	and	and	CCONJ
ajlm-2617	61	7	side	side	NOUN
ajlm-2617	61	8	scatter	scatter	NOUN
ajlm-2617	61	9	properties	property	NOUN
ajlm-2617	61	10	,	,	PUNCT
ajlm-2617	61	11	the	the	DET
ajlm-2617	61	12	xn	xn	PROPN
ajlm-2617	61	13	-	-	PUNCT
ajlm-2617	61	14	series	series	NOUN
ajlm-2617	61	15	classified	classify	VERB
ajlm-2617	61	16	‘	'	PUNCT
ajlm-2617	61	17	hairy	hairy	ADJ
ajlm-2617	61	18	cells	cell	NOUN
ajlm-2617	61	19	’	'	PUNCT
ajlm-2617	61	20	as	as	ADP
ajlm-2617	61	21	monocytes	monocyte	NOUN
ajlm-2617	61	22	,	,	PUNCT
ajlm-2617	61	23	which	which	PRON
ajlm-2617	61	24	resulted	result	VERB
ajlm-2617	61	25	in	in	ADP
ajlm-2617	61	26	a	a	DET
ajlm-2617	61	27	spurious	spurious	ADJ
ajlm-2617	61	28	‘	'	PUNCT
ajlm-2617	61	29	monocytosis	monocytosis	ADJ
ajlm-2617	61	30	’	'	PUNCT
ajlm-2617	61	31	flag	flag	NOUN
ajlm-2617	61	32	.	.	PUNCT
ajlm-2617	62	1	no	no	DET
ajlm-2617	62	2	white	white	ADJ
ajlm-2617	62	3	cell	cell	NOUN
ajlm-2617	62	4	precursor	precursor	NOUN
ajlm-2617	62	5	scatterplot	scatterplot	NOUN
ajlm-2617	62	6	was	be	AUX
ajlm-2617	62	7	generated	generate	VERB
ajlm-2617	62	8	by	by	ADP
ajlm-2617	62	9	the	the	DET
ajlm-2617	62	10	instrument	instrument	NOUN
ajlm-2617	62	11	,	,	PUNCT
ajlm-2617	62	12	suggesting	suggest	VERB
ajlm-2617	62	13	that	that	SCONJ
ajlm-2617	62	14	the	the	DET
ajlm-2617	62	15	white	white	ADJ
ajlm-2617	62	16	cell	cell	NOUN
ajlm-2617	62	17	precursor	precursor	NOUN
ajlm-2617	62	18	channel	channel	NOUN
ajlm-2617	62	19	(	(	PUNCT
ajlm-2617	62	20	which	which	PRON
ajlm-2617	62	21	detects	detect	VERB
ajlm-2617	62	22	abnormal	abnormal	ADJ
ajlm-2617	62	23	lymphocytes	lymphocyte	NOUN
ajlm-2617	62	24	or	or	CCONJ
ajlm-2617	62	25	blasts	blast	NOUN
ajlm-2617	62	26	)	)	PUNCT
ajlm-2617	62	27	was	be	AUX
ajlm-2617	62	28	not	not	PART
ajlm-2617	62	29	reflexed	reflexe	VERB
ajlm-2617	62	30	.	.	PUNCT
ajlm-2617	63	1	similarly	similarly	ADV
ajlm-2617	63	2	,	,	PUNCT
ajlm-2617	63	3	in	in	ADP
ajlm-2617	63	4	five	five	NUM
ajlm-2617	63	5	of	of	ADP
ajlm-2617	63	6	six	six	NUM
ajlm-2617	63	7	hcl	hcl	PROPN
ajlm-2617	63	8	cases	case	NOUN
ajlm-2617	63	9	evaluated	evaluate	VERB
ajlm-2617	63	10	by	by	ADP
ajlm-2617	63	11	tofan	tofan	NOUN
ajlm-2617	63	12	et	et	PROPN
ajlm-2617	63	13	al.3	al.3	PROPN
ajlm-2617	63	14	,	,	PUNCT
ajlm-2617	63	15	a	a	DET
ajlm-2617	63	16	pseudomonocytosis	pseudomonocytosis	NOUN
ajlm-2617	63	17	was	be	AUX
ajlm-2617	63	18	generated	generate	VERB
ajlm-2617	63	19	when	when	SCONJ
ajlm-2617	63	20	automated	automate	VERB
ajlm-2617	63	21	differential	differential	NOUN
ajlm-2617	63	22	counts	count	NOUN
ajlm-2617	63	23	were	be	AUX
ajlm-2617	63	24	performed	perform	VERB
ajlm-2617	63	25	on	on	ADP
ajlm-2617	63	26	the	the	DET
ajlm-2617	63	27	sysmex	sysmex	NOUN
ajlm-2617	63	28	xn	xn	NOUN
ajlm-2617	63	29	-	-	PUNCT
ajlm-2617	63	30	series	series	NOUN
ajlm-2617	63	31	.	.	PUNCT
ajlm-2617	64	1	this	this	DET
ajlm-2617	64	2	impaired	impaired	ADJ
ajlm-2617	64	3	separation	separation	NOUN
ajlm-2617	64	4	of	of	ADP
ajlm-2617	64	5	mononuclear	mononuclear	ADJ
ajlm-2617	64	6	cells	cell	NOUN
ajlm-2617	64	7	was	be	AUX
ajlm-2617	64	8	ascribed	ascribe	VERB
ajlm-2617	64	9	to	to	ADP
ajlm-2617	64	10	the	the	DET
ajlm-2617	64	11	larger	large	ADJ
ajlm-2617	64	12	size	size	NOUN
ajlm-2617	64	13	and	and	CCONJ
ajlm-2617	64	14	more	more	ADV
ajlm-2617	64	15	abundant	abundant	ADJ
ajlm-2617	64	16	cytoplasm	cytoplasm	NOUN
ajlm-2617	64	17	of	of	ADP
ajlm-2617	64	18	the	the	DET
ajlm-2617	64	19	leukaemic	leukaemic	ADJ
ajlm-2617	64	20	cells.3	cells.3	NOUN
ajlm-2617	64	21	figure	figure	NOUN
ajlm-2617	64	22	3	3	NUM
ajlm-2617	64	23	:	:	PUNCT
ajlm-2617	64	24	(	(	PUNCT
ajlm-2617	64	25	a	a	X
ajlm-2617	64	26	)	)	PUNCT
ajlm-2617	64	27	the	the	DET
ajlm-2617	64	28	white	white	PROPN
ajlm-2617	64	29	cell	cell	PROPN
ajlm-2617	64	30	differential	differential	NOUN
ajlm-2617	64	31	channel	channel	NOUN
ajlm-2617	64	32	on	on	ADP
ajlm-2617	64	33	the	the	DET
ajlm-2617	64	34	xn	xn	PROPN
ajlm-2617	64	35	-	-	PUNCT
ajlm-2617	64	36	series	series	NOUN
ajlm-2617	64	37	(	(	PUNCT
ajlm-2617	64	38	sysmex	sysmex	NOUN
ajlm-2617	64	39	corporation	corporation	NOUN
ajlm-2617	64	40	,	,	PUNCT
ajlm-2617	64	41	kobe	kobe	PROPN
ajlm-2617	64	42	,	,	PUNCT
ajlm-2617	64	43	japan	japan	PROPN
ajlm-2617	64	44	)	)	PUNCT
ajlm-2617	64	45	primarily	primarily	ADV
ajlm-2617	64	46	classifies	classify	VERB
ajlm-2617	64	47	white	white	ADJ
ajlm-2617	64	48	blood	blood	NOUN
ajlm-2617	64	49	cells	cell	NOUN
ajlm-2617	64	50	.	.	PUNCT
ajlm-2617	65	1	this	this	DET
ajlm-2617	65	2	normal	normal	ADJ
ajlm-2617	65	3	scattergram	scattergram	NOUN
ajlm-2617	65	4	displays	display	NOUN
ajlm-2617	65	5	lymphocytes	lymphocyte	NOUN
ajlm-2617	65	6	,	,	PUNCT
ajlm-2617	65	7	monocytes	monocyte	NOUN
ajlm-2617	65	8	,	,	PUNCT
ajlm-2617	65	9	eosinophils	eosinophil	NOUN
ajlm-2617	65	10	,	,	PUNCT
ajlm-2617	65	11	basophils	basophil	NOUN
ajlm-2617	65	12	,	,	PUNCT
ajlm-2617	65	13	neutrophils	neutrophil	NOUN
ajlm-2617	65	14	,	,	PUNCT
ajlm-2617	65	15	and	and	CCONJ
ajlm-2617	65	16	debris.13,14	debris.13,14	ADJ
ajlm-2617	65	17	(	(	PUNCT
ajlm-2617	65	18	b	b	X
ajlm-2617	65	19	)	)	PUNCT
ajlm-2617	65	20	the	the	DET
ajlm-2617	65	21	white	white	PROPN
ajlm-2617	65	22	cell	cell	PROPN
ajlm-2617	65	23	differential	differential	PROPN
ajlm-2617	65	24	scattergram	scattergram	NOUN
ajlm-2617	65	25	for	for	ADP
ajlm-2617	65	26	our	our	PRON
ajlm-2617	65	27	case	case	NOUN
ajlm-2617	65	28	,	,	PUNCT
ajlm-2617	65	29	performed	perform	VERB
ajlm-2617	65	30	on	on	ADP
ajlm-2617	65	31	a	a	DET
ajlm-2617	65	32	sysmex	sysmex	NOUN
ajlm-2617	65	33	xn-1000	xn-1000	NOUN
ajlm-2617	65	34	at	at	ADP
ajlm-2617	65	35	a	a	DET
ajlm-2617	65	36	regional	regional	ADJ
ajlm-2617	65	37	laboratory	laboratory	NOUN
ajlm-2617	65	38	in	in	ADP
ajlm-2617	65	39	north	north	PROPN
ajlm-2617	65	40	west	west	PROPN
ajlm-2617	65	41	province	province	PROPN
ajlm-2617	65	42	,	,	PUNCT
ajlm-2617	65	43	south	south	PROPN
ajlm-2617	65	44	africa	africa	PROPN
ajlm-2617	65	45	in	in	ADP
ajlm-2617	65	46	june	june	PROPN
ajlm-2617	65	47	2023	2023	NUM
ajlm-2617	65	48	,	,	PUNCT
ajlm-2617	65	49	demonstrated	demonstrate	VERB
ajlm-2617	65	50	a	a	DET
ajlm-2617	65	51	large	large	ADJ
ajlm-2617	65	52	population	population	NOUN
ajlm-2617	65	53	of	of	ADP
ajlm-2617	65	54	cells	cell	NOUN
ajlm-2617	65	55	in	in	ADP
ajlm-2617	65	56	the	the	DET
ajlm-2617	65	57	‘	'	PUNCT
ajlm-2617	65	58	monocyte	monocyte	NOUN
ajlm-2617	65	59	window	window	NOUN
ajlm-2617	65	60	’	'	PUNCT
ajlm-2617	65	61	.	.	PUNCT
ajlm-2617	66	1	the	the	DET
ajlm-2617	66	2	wbc	wbc	ADJ
ajlm-2617	66	3	flagging	flagging	ADJ
ajlm-2617	66	4	performance	performance	NOUN
ajlm-2617	66	5	of	of	ADP
ajlm-2617	66	6	the	the	DET
ajlm-2617	66	7	xn	xn	NOUN
ajlm-2617	66	8	-	-	PUNCT
ajlm-2617	66	9	series	series	NOUN
ajlm-2617	66	10	has	have	AUX
ajlm-2617	66	11	been	be	AUX
ajlm-2617	66	12	evaluated	evaluate	VERB
ajlm-2617	66	13	in	in	ADP
ajlm-2617	66	14	several	several	ADJ
ajlm-2617	66	15	studies	study	NOUN
ajlm-2617	66	16	,	,	PUNCT
ajlm-2617	66	17	including	include	VERB
ajlm-2617	66	18	two	two	NUM
ajlm-2617	66	19	local	local	ADJ
ajlm-2617	66	20	studies	study	NOUN
ajlm-2617	66	21	performed	perform	VERB
ajlm-2617	66	22	in	in	ADP
ajlm-2617	66	23	nhls	nhls	ADJ
ajlm-2617	66	24	laboratories.8,15,16	laboratories.8,15,16	ADJ
ajlm-2617	66	25	ramiah	ramiah	NOUN
ajlm-2617	66	26	et	et	PROPN
ajlm-2617	66	27	al.8	al.8	PROPN
ajlm-2617	66	28	demonstrated	demonstrate	VERB
ajlm-2617	66	29	sensitivities	sensitivity	NOUN
ajlm-2617	66	30	and	and	CCONJ
ajlm-2617	66	31	specificities	specificity	NOUN
ajlm-2617	66	32	of	of	ADP
ajlm-2617	66	33	90	90	NUM
ajlm-2617	66	34	%	%	NOUN
ajlm-2617	66	35	and	and	CCONJ
ajlm-2617	66	36	96.2	96.2	NUM
ajlm-2617	66	37	%	%	NOUN
ajlm-2617	66	38	for	for	ADP
ajlm-2617	66	39	the	the	DET
ajlm-2617	66	40	‘	'	PUNCT
ajlm-2617	66	41	abnormal	abnormal	ADJ
ajlm-2617	66	42	lymphocyte	lymphocyte	ADJ
ajlm-2617	66	43	’	'	PUNCT
ajlm-2617	66	44	flag	flag	NOUN
ajlm-2617	66	45	,	,	PUNCT
ajlm-2617	66	46	and	and	CCONJ
ajlm-2617	66	47	84.3	84.3	NUM
ajlm-2617	66	48	%	%	NOUN
ajlm-2617	66	49	and	and	CCONJ
ajlm-2617	66	50	97	97	NUM
ajlm-2617	66	51	%	%	NOUN
ajlm-2617	66	52	for	for	ADP
ajlm-2617	66	53	the	the	DET
ajlm-2617	66	54	‘	'	PUNCT
ajlm-2617	66	55	monocytosis	monocytosis	ADJ
ajlm-2617	66	56	’	'	PUNCT
ajlm-2617	66	57	flag	flag	NOUN
ajlm-2617	66	58	.	.	PUNCT
ajlm-2617	67	1	three	three	NUM
ajlm-2617	67	2	samples	sample	NOUN
ajlm-2617	67	3	(	(	PUNCT
ajlm-2617	67	4	1.2	1.2	NUM
ajlm-2617	67	5	%	%	NOUN
ajlm-2617	67	6	)	)	PUNCT
ajlm-2617	67	7	were	be	AUX
ajlm-2617	67	8	erroneously	erroneously	ADV
ajlm-2617	67	9	flagged	flag	VERB
ajlm-2617	67	10	as	as	ADP
ajlm-2617	67	11	‘	'	PUNCT
ajlm-2617	67	12	monocytosis	monocytosis	NOUN
ajlm-2617	67	13	’	'	PUNCT
ajlm-2617	67	14	where	where	SCONJ
ajlm-2617	67	15	blasts	blast	NOUN
ajlm-2617	67	16	were	be	AUX
ajlm-2617	67	17	demonstrated	demonstrate	VERB
ajlm-2617	67	18	on	on	ADP
ajlm-2617	67	19	microscopy.8	microscopy.8	PROPN
ajlm-2617	67	20	schapkaitz	schapkaitz	NOUN
ajlm-2617	67	21	et	et	PROPN
ajlm-2617	67	22	al.16	al.16	PROPN
ajlm-2617	67	23	evaluated	evaluate	VERB
ajlm-2617	67	24	the	the	DET
ajlm-2617	67	25	performance	performance	NOUN
ajlm-2617	67	26	of	of	ADP
ajlm-2617	67	27	the	the	DET
ajlm-2617	67	28	sysmex	sysmex	NOUN
ajlm-2617	67	29	xn-9000	xn-9000	PROPN
ajlm-2617	67	30	and	and	CCONJ
ajlm-2617	67	31	found	find	VERB
ajlm-2617	67	32	the	the	DET
ajlm-2617	67	33	white	white	ADJ
ajlm-2617	67	34	cell	cell	NOUN
ajlm-2617	67	35	differential	differential	NOUN
ajlm-2617	67	36	and	and	CCONJ
ajlm-2617	67	37	white	white	ADJ
ajlm-2617	67	38	cell	cell	NOUN
ajlm-2617	67	39	precursor	precursor	NOUN
ajlm-2617	67	40	channels	channel	NOUN
ajlm-2617	67	41	to	to	PART
ajlm-2617	67	42	be	be	AUX
ajlm-2617	67	43	100	100	NUM
ajlm-2617	67	44	%	%	NOUN
ajlm-2617	67	45	sensitive	sensitive	ADJ
ajlm-2617	67	46	for	for	ADP
ajlm-2617	67	47	detecting	detect	VERB
ajlm-2617	67	48	abnormal	abnormal	ADJ
ajlm-2617	67	49	lymphocytes	lymphocyte	NOUN
ajlm-2617	67	50	.	.	PUNCT
ajlm-2617	68	1	however	however	ADV
ajlm-2617	68	2	,	,	PUNCT
ajlm-2617	68	3	neither	neither	PRON
ajlm-2617	68	4	of	of	ADP
ajlm-2617	68	5	these	these	DET
ajlm-2617	68	6	studies	study	NOUN
ajlm-2617	68	7	included	include	VERB
ajlm-2617	68	8	hcl	hcl	PROPN
ajlm-2617	68	9	cases	case	NOUN
ajlm-2617	68	10	.	.	PUNCT
ajlm-2617	69	1	the	the	DET
ajlm-2617	69	2	limitations	limitation	NOUN
ajlm-2617	69	3	of	of	ADP
ajlm-2617	69	4	sysmex	sysmex	NOUN
ajlm-2617	69	5	automated	automate	VERB
ajlm-2617	69	6	fbc	fbc	PROPN
ajlm-2617	69	7	haematology	haematology	NOUN
ajlm-2617	69	8	analysers	analyser	NOUN
ajlm-2617	69	9	in	in	ADP
ajlm-2617	69	10	flagging	flag	VERB
ajlm-2617	69	11	abnormal	abnormal	ADJ
ajlm-2617	69	12	results	result	NOUN
ajlm-2617	69	13	in	in	ADP
ajlm-2617	69	14	hcl	hcl	PROPN
ajlm-2617	69	15	have	have	AUX
ajlm-2617	69	16	not	not	PART
ajlm-2617	69	17	been	be	AUX
ajlm-2617	69	18	widely	widely	ADV
ajlm-2617	69	19	reported	report	VERB
ajlm-2617	69	20	.	.	PUNCT
ajlm-2617	70	1	furundarena	furundarena	PROPN
ajlm-2617	70	2	et	et	PROPN
ajlm-2617	70	3	al.11	al.11	PROPN
ajlm-2617	70	4	compared	compare	VERB
ajlm-2617	70	5	the	the	DET
ajlm-2617	70	6	performance	performance	NOUN
ajlm-2617	70	7	of	of	ADP
ajlm-2617	70	8	sysmex	sysmex	NOUN
ajlm-2617	70	9	xn	xn	PROPN
ajlm-2617	70	10	and	and	CCONJ
ajlm-2617	70	11	xe-5000	xe-5000	PROPN
ajlm-2617	70	12	analysers	analyser	NOUN
ajlm-2617	70	13	in	in	ADP
ajlm-2617	70	14	oncohaematologic	oncohaematologic	NOUN
ajlm-2617	70	15	patients	patient	NOUN
ajlm-2617	70	16	and	and	CCONJ
ajlm-2617	70	17	concluded	conclude	VERB
ajlm-2617	70	18	that	that	SCONJ
ajlm-2617	70	19	both	both	DET
ajlm-2617	70	20	instruments	instrument	NOUN
ajlm-2617	70	21	must	must	AUX
ajlm-2617	70	22	improve	improve	VERB
ajlm-2617	70	23	flagging	flag	VERB
ajlm-2617	70	24	in	in	ADP
ajlm-2617	70	25	hcl	hcl	PROPN
ajlm-2617	70	26	.	.	PUNCT
ajlm-2617	71	1	both	both	DET
ajlm-2617	71	2	analysers	analyser	NOUN
ajlm-2617	71	3	only	only	ADV
ajlm-2617	71	4	generated	generate	VERB
ajlm-2617	71	5	one	one	NUM
ajlm-2617	71	6	flag	flag	NOUN
ajlm-2617	71	7	(	(	PUNCT
ajlm-2617	71	8	‘	'	PUNCT
ajlm-2617	71	9	abn	abn	NOUN
ajlm-2617	71	10	lympho	lympho	NOUN
ajlm-2617	71	11	/	/	SYM
ajlm-2617	71	12	blasts	blast	NOUN
ajlm-2617	71	13	?	?	PUNCT
ajlm-2617	71	14	’	'	PUNCT
ajlm-2617	71	15	)	)	PUNCT
ajlm-2617	71	16	in	in	ADP
ajlm-2617	71	17	one	one	NUM
ajlm-2617	71	18	out	out	ADP
ajlm-2617	71	19	of	of	ADP
ajlm-2617	71	20	five	five	NUM
ajlm-2617	71	21	hcl	hcl	PROPN
ajlm-2617	71	22	samples	sample	NOUN
ajlm-2617	71	23	included	include	VERB
ajlm-2617	71	24	in	in	ADP
ajlm-2617	71	25	their	their	PRON
ajlm-2617	71	26	study.11	study.11	NOUN
ajlm-2617	71	27	considering	consider	VERB
ajlm-2617	71	28	the	the	DET
ajlm-2617	71	29	rarity	rarity	NOUN
ajlm-2617	71	30	of	of	ADP
ajlm-2617	71	31	hcl	hcl	PROPN
ajlm-2617	71	32	,	,	PUNCT
ajlm-2617	71	33	this	this	DET
ajlm-2617	71	34	neoplasm	neoplasm	NOUN
ajlm-2617	71	35	may	may	AUX
ajlm-2617	71	36	be	be	AUX
ajlm-2617	71	37	underrepresented	underrepresente	VERB
ajlm-2617	71	38	in	in	ADP
ajlm-2617	71	39	the	the	DET
ajlm-2617	71	40	verification	verification	NOUN
ajlm-2617	71	41	studies	study	NOUN
ajlm-2617	71	42	of	of	ADP
ajlm-2617	71	43	xn	xn	PROPN
ajlm-2617	71	44	-	-	PUNCT
ajlm-2617	71	45	series	series	NOUN
ajlm-2617	71	46	analysers	analyser	NOUN
ajlm-2617	71	47	that	that	PRON
ajlm-2617	71	48	have	have	AUX
ajlm-2617	71	49	been	be	AUX
ajlm-2617	71	50	performed	perform	VERB
ajlm-2617	71	51	to	to	ADP
ajlm-2617	71	52	date	date	NOUN
ajlm-2617	71	53	.	.	PUNCT
ajlm-2617	72	1	further	furth	ADJ
ajlm-2617	72	2	studies	study	NOUN
ajlm-2617	72	3	are	be	AUX
ajlm-2617	72	4	needed	need	VERB
ajlm-2617	72	5	to	to	PART
ajlm-2617	72	6	evaluate	evaluate	VERB
ajlm-2617	72	7	the	the	DET
ajlm-2617	72	8	performance	performance	NOUN
ajlm-2617	72	9	of	of	ADP
ajlm-2617	72	10	the	the	DET
ajlm-2617	72	11	xn	xn	PROPN
ajlm-2617	72	12	-	-	PUNCT
ajlm-2617	72	13	series	series	NOUN
ajlm-2617	72	14	,	,	PUNCT
ajlm-2617	72	15	specifically	specifically	ADV
ajlm-2617	72	16	in	in	ADP
ajlm-2617	72	17	hcl	hcl	PROPN
ajlm-2617	72	18	.	.	PUNCT
ajlm-2617	73	1	conclusion	conclusion	NOUN
ajlm-2617	73	2	monocytopenia	monocytopenia	NOUN
ajlm-2617	73	3	may	may	AUX
ajlm-2617	73	4	prompt	prompt	VERB
ajlm-2617	73	5	early	early	ADJ
ajlm-2617	73	6	investigation	investigation	NOUN
ajlm-2617	73	7	for	for	ADP
ajlm-2617	73	8	hcl	hcl	PROPN
ajlm-2617	73	9	in	in	ADP
ajlm-2617	73	10	the	the	DET
ajlm-2617	73	11	right	right	ADJ
ajlm-2617	73	12	clinical	clinical	ADJ
ajlm-2617	73	13	scenario	scenario	NOUN
ajlm-2617	73	14	.	.	PUNCT
ajlm-2617	74	1	however	however	ADV
ajlm-2617	74	2	,	,	PUNCT
ajlm-2617	74	3	haematology	haematology	NOUN
ajlm-2617	74	4	analysers	analyser	NOUN
ajlm-2617	74	5	,	,	PUNCT
ajlm-2617	74	6	such	such	ADJ
ajlm-2617	74	7	as	as	ADP
ajlm-2617	74	8	the	the	DET
ajlm-2617	74	9	sysmex	sysmex	NOUN
ajlm-2617	74	10	xn	xn	NOUN
ajlm-2617	74	11	-	-	PUNCT
ajlm-2617	74	12	series	series	NOUN
ajlm-2617	74	13	,	,	PUNCT
ajlm-2617	74	14	that	that	PRON
ajlm-2617	74	15	rely	rely	VERB
ajlm-2617	74	16	on	on	SCONJ
ajlm-2617	74	17	cytochemistry	cytochemistry	NOUN
ajlm-2617	74	18	with	with	ADP
ajlm-2617	74	19	fluorescence	fluorescence	NOUN
ajlm-2617	74	20	flow	flow	NOUN
ajlm-2617	74	21	cytometry	cytometry	NOUN
ajlm-2617	74	22	may	may	AUX
ajlm-2617	74	23	artifactually	artifactually	ADV
ajlm-2617	74	24	report	report	VERB
ajlm-2617	74	25	‘	'	PUNCT
ajlm-2617	74	26	monocytosis	monocytosis	NOUN
ajlm-2617	74	27	’	'	PUNCT
ajlm-2617	74	28	in	in	ADP
ajlm-2617	74	29	hcl	hcl	PROPN
ajlm-2617	74	30	.	.	PUNCT
ajlm-2617	75	1	with	with	ADP
ajlm-2617	75	2	the	the	DET
ajlm-2617	75	3	nationwide	nationwide	ADJ
ajlm-2617	75	4	introduction	introduction	NOUN
ajlm-2617	75	5	of	of	ADP
ajlm-2617	75	6	the	the	DET
ajlm-2617	75	7	sysmex	sysmex	NOUN
ajlm-2617	75	8	xn	xn	NOUN
ajlm-2617	75	9	-	-	PUNCT
ajlm-2617	75	10	series	series	NOUN
ajlm-2617	75	11	in	in	ADP
ajlm-2617	75	12	nhls	nhls	PROPN
ajlm-2617	75	13	laboratories	laboratory	NOUN
ajlm-2617	75	14	,	,	PUNCT
ajlm-2617	75	15	this	this	DET
ajlm-2617	75	16	case	case	NOUN
ajlm-2617	75	17	serves	serve	VERB
ajlm-2617	75	18	as	as	ADP
ajlm-2617	75	19	a	a	DET
ajlm-2617	75	20	reminder	reminder	NOUN
ajlm-2617	75	21	that	that	SCONJ
ajlm-2617	75	22	a	a	DET
ajlm-2617	75	23	manual	manual	ADJ
ajlm-2617	75	24	differential	differential	ADJ
ajlm-2617	75	25	count	count	NOUN
ajlm-2617	75	26	and	and	CCONJ
ajlm-2617	75	27	morphologic	morphologic	ADJ
ajlm-2617	75	28	review	review	NOUN
ajlm-2617	75	29	of	of	ADP
ajlm-2617	75	30	suspicious	suspicious	ADJ
ajlm-2617	75	31	results	result	NOUN
ajlm-2617	75	32	remain	remain	VERB
ajlm-2617	75	33	important	important	ADJ
ajlm-2617	75	34	in	in	ADP
ajlm-2617	75	35	the	the	DET
ajlm-2617	75	36	era	era	NOUN
ajlm-2617	75	37	of	of	ADP
ajlm-2617	75	38	automation	automation	NOUN
ajlm-2617	75	39	.	.	PUNCT
ajlm-2617	76	1	acknowledgements	acknowledgement	NOUN
ajlm-2617	76	2	competing	compete	VERB
ajlm-2617	76	3	interests	interest	NOUN
ajlm-2617	76	4	the	the	DET
ajlm-2617	76	5	authors	author	NOUN
ajlm-2617	76	6	declare	declare	VERB
ajlm-2617	76	7	that	that	SCONJ
ajlm-2617	76	8	they	they	PRON
ajlm-2617	76	9	have	have	VERB
ajlm-2617	76	10	no	no	DET
ajlm-2617	76	11	financial	financial	ADJ
ajlm-2617	76	12	or	or	CCONJ
ajlm-2617	76	13	personal	personal	ADJ
ajlm-2617	76	14	relationships	relationship	NOUN
ajlm-2617	76	15	that	that	PRON
ajlm-2617	76	16	may	may	AUX
ajlm-2617	76	17	have	have	AUX
ajlm-2617	76	18	inappropriately	inappropriately	ADV
ajlm-2617	76	19	influenced	influence	VERB
ajlm-2617	76	20	them	they	PRON
ajlm-2617	76	21	in	in	ADP
ajlm-2617	76	22	writing	write	VERB
ajlm-2617	76	23	this	this	DET
ajlm-2617	76	24	article	article	NOUN
ajlm-2617	76	25	.	.	PUNCT
ajlm-2617	77	1	authors	author	NOUN
ajlm-2617	77	2	’	’	PART
ajlm-2617	77	3	contributions	contribution	NOUN
ajlm-2617	77	4	s.j.k	s.j.k	PROPN
ajlm-2617	77	5	.	.	PUNCT
ajlm-2617	78	1	and	and	CCONJ
ajlm-2617	78	2	a.-c.v.m	a.-c.v.m	NOUN
ajlm-2617	78	3	.	.	PUNCT
ajlm-2617	78	4	contributed	contribute	VERB
ajlm-2617	78	5	to	to	ADP
ajlm-2617	78	6	the	the	DET
ajlm-2617	78	7	conceptualisation	conceptualisation	NOUN
ajlm-2617	78	8	and	and	CCONJ
ajlm-2617	78	9	design	design	NOUN
ajlm-2617	78	10	of	of	ADP
ajlm-2617	78	11	the	the	DET
ajlm-2617	78	12	case	case	NOUN
ajlm-2617	78	13	report	report	NOUN
ajlm-2617	78	14	,	,	PUNCT
ajlm-2617	78	15	and	and	CCONJ
ajlm-2617	78	16	the	the	DET
ajlm-2617	78	17	collection	collection	NOUN
ajlm-2617	78	18	and	and	CCONJ
ajlm-2617	78	19	interpretation	interpretation	NOUN
ajlm-2617	78	20	of	of	ADP
ajlm-2617	78	21	data	data	PROPN
ajlm-2617	78	22	.	.	PUNCT
ajlm-2617	79	1	s.j.k	s.j.k	PROPN
ajlm-2617	79	2	.	.	PUNCT
ajlm-2617	80	1	and	and	CCONJ
ajlm-2617	80	2	a.-c.v.m	a.-c.v.m	NOUN
ajlm-2617	80	3	.	.	PROPN
ajlm-2617	80	4	contributed	contribute	VERB
ajlm-2617	80	5	equally	equally	ADV
ajlm-2617	80	6	to	to	ADP
ajlm-2617	80	7	writing	write	VERB
ajlm-2617	80	8	and	and	CCONJ
ajlm-2617	80	9	editing	edit	VERB
ajlm-2617	80	10	the	the	DET
ajlm-2617	80	11	case	case	NOUN
ajlm-2617	80	12	report	report	NOUN
ajlm-2617	80	13	.	.	PUNCT
ajlm-2617	81	1	the	the	DET
ajlm-2617	81	2	final	final	ADJ
ajlm-2617	81	3	article	article	NOUN
ajlm-2617	81	4	was	be	AUX
ajlm-2617	81	5	approved	approve	VERB
ajlm-2617	81	6	by	by	ADP
ajlm-2617	81	7	both	both	DET
ajlm-2617	81	8	s.j.k	s.j.k	PROPN
ajlm-2617	81	9	.	.	PUNCT
ajlm-2617	82	1	and	and	CCONJ
ajlm-2617	82	2	a.-c.v.m	a.-c.v.m	NOUN
ajlm-2617	82	3	.	.	PUNCT
ajlm-2617	83	1	sources	source	NOUN
ajlm-2617	83	2	of	of	ADP
ajlm-2617	83	3	support	support	NOUN
ajlm-2617	83	4	this	this	DET
ajlm-2617	83	5	article	article	NOUN
ajlm-2617	83	6	received	receive	VERB
ajlm-2617	83	7	no	no	DET
ajlm-2617	83	8	specific	specific	ADJ
ajlm-2617	83	9	grant	grant	NOUN
ajlm-2617	83	10	from	from	ADP
ajlm-2617	83	11	any	any	DET
ajlm-2617	83	12	funding	funding	NOUN
ajlm-2617	83	13	agency	agency	NOUN
ajlm-2617	83	14	in	in	ADP
ajlm-2617	83	15	the	the	DET
ajlm-2617	83	16	public	public	ADJ
ajlm-2617	83	17	,	,	PUNCT
ajlm-2617	83	18	commercial	commercial	ADJ
ajlm-2617	83	19	or	or	CCONJ
ajlm-2617	83	20	not	not	PART
ajlm-2617	83	21	-	-	PUNCT
ajlm-2617	83	22	for	for	ADP
ajlm-2617	83	23	-	-	PUNCT
ajlm-2617	83	24	profit	profit	NOUN
ajlm-2617	83	25	sectors	sector	NOUN
ajlm-2617	83	26	.	.	PUNCT
ajlm-2617	84	1	data	datum	NOUN
ajlm-2617	84	2	availability	availability	NOUN
ajlm-2617	84	3	the	the	DET
ajlm-2617	84	4	data	datum	NOUN
ajlm-2617	84	5	that	that	PRON
ajlm-2617	84	6	support	support	VERB
ajlm-2617	84	7	the	the	DET
ajlm-2617	84	8	findings	finding	NOUN
ajlm-2617	84	9	of	of	ADP
ajlm-2617	84	10	this	this	DET
ajlm-2617	84	11	case	case	NOUN
ajlm-2617	84	12	study	study	NOUN
ajlm-2617	84	13	are	be	AUX
ajlm-2617	84	14	available	available	ADJ
ajlm-2617	84	15	from	from	ADP
ajlm-2617	84	16	the	the	DET
ajlm-2617	84	17	corresponding	corresponding	ADJ
ajlm-2617	84	18	author	author	NOUN
ajlm-2617	84	19	,	,	PUNCT
ajlm-2617	84	20	a.-c.v.m	a.-c.v.m	NOUN
ajlm-2617	84	21	.	.	PUNCT
ajlm-2617	84	22	,	,	PUNCT
ajlm-2617	84	23	upon	upon	SCONJ
ajlm-2617	84	24	reasonable	reasonable	ADJ
ajlm-2617	84	25	request	request	NOUN
ajlm-2617	84	26	.	.	PUNCT
ajlm-2617	85	1	disclaimer	disclaimer	VERB
ajlm-2617	85	2	the	the	DET
ajlm-2617	85	3	views	view	NOUN
ajlm-2617	85	4	and	and	CCONJ
ajlm-2617	85	5	opinions	opinion	NOUN
ajlm-2617	85	6	expressed	express	VERB
ajlm-2617	85	7	in	in	ADP
ajlm-2617	85	8	this	this	DET
ajlm-2617	85	9	article	article	NOUN
ajlm-2617	85	10	are	be	AUX
ajlm-2617	85	11	those	those	PRON
ajlm-2617	85	12	of	of	ADP
ajlm-2617	85	13	the	the	DET
ajlm-2617	85	14	authors	author	NOUN
ajlm-2617	85	15	and	and	CCONJ
ajlm-2617	85	16	are	be	AUX
ajlm-2617	85	17	the	the	DET
ajlm-2617	85	18	product	product	NOUN
ajlm-2617	85	19	of	of	ADP
ajlm-2617	85	20	professional	professional	ADJ
ajlm-2617	85	21	research	research	NOUN
ajlm-2617	85	22	.	.	PUNCT
ajlm-2617	86	1	the	the	DET
ajlm-2617	86	2	article	article	NOUN
ajlm-2617	86	3	does	do	AUX
ajlm-2617	86	4	not	not	PART
ajlm-2617	86	5	necessarily	necessarily	ADV
ajlm-2617	86	6	reflect	reflect	VERB
ajlm-2617	86	7	the	the	DET
ajlm-2617	86	8	official	official	ADJ
ajlm-2617	86	9	policy	policy	NOUN
ajlm-2617	86	10	or	or	CCONJ
ajlm-2617	86	11	position	position	NOUN
ajlm-2617	86	12	of	of	ADP
ajlm-2617	86	13	any	any	DET
ajlm-2617	86	14	affiliated	affiliated	ADJ
ajlm-2617	86	15	institution	institution	NOUN
ajlm-2617	86	16	,	,	PUNCT
ajlm-2617	86	17	funder	funder	NOUN
ajlm-2617	86	18	,	,	PUNCT
ajlm-2617	86	19	agency	agency	NOUN
ajlm-2617	86	20	,	,	PUNCT
ajlm-2617	86	21	or	or	CCONJ
ajlm-2617	86	22	that	that	PRON
ajlm-2617	86	23	of	of	ADP
ajlm-2617	86	24	the	the	DET
ajlm-2617	86	25	publisher	publisher	NOUN
ajlm-2617	86	26	.	.	PUNCT
ajlm-2617	87	1	the	the	DET
ajlm-2617	87	2	authors	author	NOUN
ajlm-2617	87	3	are	be	AUX
ajlm-2617	87	4	responsible	responsible	ADJ
ajlm-2617	87	5	for	for	ADP
ajlm-2617	87	6	this	this	DET
ajlm-2617	87	7	article	article	NOUN
ajlm-2617	87	8	’s	’s	PART
ajlm-2617	87	9	results	result	NOUN
ajlm-2617	87	10	,	,	PUNCT
ajlm-2617	87	11	findings	finding	NOUN
ajlm-2617	87	12	,	,	PUNCT
ajlm-2617	87	13	and	and	CCONJ
ajlm-2617	87	14	content	content	NOUN
ajlm-2617	87	15	.	.	PUNCT
ajlm-2617	88	1	references	reference	NOUN
ajlm-2617	88	2	cross	cross	VERB
ajlm-2617	88	3	m	m	PROPN
ajlm-2617	88	4	,	,	PUNCT
ajlm-2617	88	5	dearden	dearden	ADJ
ajlm-2617	88	6	c.	c.	PROPN
ajlm-2617	88	7	hairy	hairy	ADJ
ajlm-2617	88	8	cell	cell	NOUN
ajlm-2617	88	9	leukaemia	leukaemia	NOUN
ajlm-2617	88	10	.	.	PUNCT
ajlm-2617	89	1	curr	curr	PROPN
ajlm-2617	89	2	oncol	oncol	PROPN
ajlm-2617	89	3	rep	rep	PROPN
ajlm-2617	89	4	.	.	PROPN
ajlm-2617	90	1	2020;22(5):42	2020;22(5):42	NUM
ajlm-2617	90	2	.	.	PROPN
ajlm-2617	90	3	https://doi.org/10.1007/s11912-020-00911-0	https://doi.org/10.1007/s11912-020-00911-0	VERB
ajlm-2617	90	4	parry	parry	PROPN
ajlm-2617	90	5	-	-	PUNCT
ajlm-2617	90	6	jones	jones	PROPN
ajlm-2617	90	7	n	n	PROPN
ajlm-2617	90	8	,	,	PUNCT
ajlm-2617	90	9	joshi	joshi	PROPN
ajlm-2617	90	10	a	a	X
ajlm-2617	90	11	,	,	PUNCT
ajlm-2617	90	12	forconi	forconi	PROPN
ajlm-2617	90	13	f	f	PROPN
ajlm-2617	90	14	,	,	PUNCT
ajlm-2617	90	15	dearden	dearden	ADJ
ajlm-2617	91	1	c	c	NOUN
ajlm-2617	91	2	;	;	PUNCT
ajlm-2617	91	3	bsh	bsh	PROPN
ajlm-2617	91	4	guidelines	guideline	NOUN
ajlm-2617	91	5	committee	committee	NOUN
ajlm-2617	91	6	.	.	PUNCT
ajlm-2617	92	1	guideline	guideline	NOUN
ajlm-2617	92	2	for	for	ADP
ajlm-2617	92	3	diagnosis	diagnosis	NOUN
ajlm-2617	92	4	and	and	CCONJ
ajlm-2617	92	5	management	management	NOUN
ajlm-2617	92	6	of	of	ADP
ajlm-2617	92	7	hairy	hairy	ADJ
ajlm-2617	92	8	cell	cell	NOUN
ajlm-2617	92	9	leukaemia	leukaemia	NOUN
ajlm-2617	92	10	(	(	PUNCT
ajlm-2617	92	11	hcl	hcl	PROPN
ajlm-2617	92	12	)	)	PUNCT
ajlm-2617	92	13	and	and	CCONJ
ajlm-2617	92	14	hairy	hairy	ADJ
ajlm-2617	92	15	cell	cell	NOUN
ajlm-2617	92	16	variant	variant	NOUN
ajlm-2617	92	17	(	(	PUNCT
ajlm-2617	92	18	hcl	hcl	PROPN
ajlm-2617	92	19	-	-	PUNCT
ajlm-2617	92	20	v	v	NOUN
ajlm-2617	92	21	)	)	PUNCT
ajlm-2617	92	22	.	.	PUNCT
ajlm-2617	93	1	br	br	PROPN
ajlm-2617	93	2	j	j	PROPN
ajlm-2617	93	3	haematol	haematol	NOUN
ajlm-2617	93	4	.	.	PUNCT
ajlm-2617	94	1	2020;191(5):730–737	2020;191(5):730–737	X
ajlm-2617	94	2	.	.	X
ajlm-2617	94	3	https://doi.org/10.1111/bjh.17055	https://doi.org/10.1111/bjh.17055	PROPN
ajlm-2617	94	4	tofan	tofan	PROPN
ajlm-2617	94	5	l	l	PROPN
ajlm-2617	94	6	,	,	PUNCT
ajlm-2617	94	7	piqueras	piqueras	PROPN
ajlm-2617	94	8	m	m	PROPN
ajlm-2617	94	9	,	,	PUNCT
ajlm-2617	94	10	fuster	fuster	ADJ
ajlm-2617	94	11	o	o	NOUN
ajlm-2617	94	12	,	,	PUNCT
ajlm-2617	94	13	et	et	PROPN
ajlm-2617	94	14	al	al	PROPN
ajlm-2617	94	15	.	.	PROPN
ajlm-2617	94	16	monocytopenia	monocytopenia	PROPN
ajlm-2617	94	17	in	in	ADP
ajlm-2617	94	18	hairy	hairy	ADJ
ajlm-2617	94	19	cell	cell	NOUN
ajlm-2617	94	20	leukemia	leukemia	NOUN
ajlm-2617	94	21	,	,	PUNCT
ajlm-2617	94	22	a	a	DET
ajlm-2617	94	23	difficult	difficult	ADJ
ajlm-2617	94	24	feature	feature	NOUN
ajlm-2617	94	25	to	to	PART
ajlm-2617	94	26	detect	detect	VERB
ajlm-2617	94	27	using	use	VERB
ajlm-2617	94	28	sysmex	sysmex	NOUN
ajlm-2617	94	29	xn	xn	PROPN
ajlm-2617	94	30	series	series	PROPN
ajlm-2617	94	31	hematology	hematology	PROPN
ajlm-2617	94	32	analyzer	analyzer	NOUN
ajlm-2617	94	33	.	.	PUNCT
ajlm-2617	95	1	int	int	PROPN
ajlm-2617	96	1	j	j	PROPN
ajlm-2617	96	2	fam	fam	PROPN
ajlm-2617	96	3	commun	commun	PROPN
ajlm-2617	96	4	med	med	PROPN
ajlm-2617	96	5	.	.	PUNCT
ajlm-2617	97	1	2022;6(3):94–97	2022;6(3):94–97	NUM
ajlm-2617	97	2	.	.	PUNCT
ajlm-2617	98	1	https://doi.org/10.15406/ijfcm.2022.06.00271	https://doi.org/10.15406/ijfcm.2022.06.00271	NOUN
ajlm-2617	98	2	bigorra	bigorra	PROPN
ajlm-2617	98	3	l	l	PROPN
ajlm-2617	98	4	,	,	PUNCT
ajlm-2617	98	5	larriba	larriba	VERB
ajlm-2617	98	6	i	i	PRON
ajlm-2617	98	7	,	,	PUNCT
ajlm-2617	98	8	gutiérrez	gutiérrez	NOUN
ajlm-2617	98	9	-	-	PUNCT
ajlm-2617	98	10	gallego	gallego	NOUN
ajlm-2617	98	11	r.	r.	NOUN
ajlm-2617	99	1	the	the	DET
ajlm-2617	99	2	hairy	hairy	ADJ
ajlm-2617	99	3	cell	cell	NOUN
ajlm-2617	99	4	leukaemia	leukaemia	NOUN
ajlm-2617	99	5	oxymoron	oxymoron	NOUN
ajlm-2617	99	6	:	:	PUNCT
ajlm-2617	99	7	monocytotic	monocytotic	ADJ
ajlm-2617	99	8	monocytopenia	monocytopenia	PROPN
ajlm-2617	99	9	.	.	PUNCT
ajlm-2617	100	1	clin	clin	PROPN
ajlm-2617	100	2	chem	chem	NOUN
ajlm-2617	100	3	lab	lab	NOUN
ajlm-2617	100	4	med	me	VERB
ajlm-2617	100	5	.	.	PUNCT
ajlm-2617	101	1	2020;59(3):e111	2020;59(3):e111	NUM
ajlm-2617	101	2	–	–	PUNCT
ajlm-2617	101	3	e115	e115	PROPN
ajlm-2617	101	4	.	.	PUNCT
ajlm-2617	102	1	https://doi.org/10.1515/cclm-2020-0253	https://doi.org/10.1515/cclm-2020-0253	PROPN
ajlm-2617	102	2	lynch	lynch	PROPN
ajlm-2617	102	3	dt	dt	PROPN
ajlm-2617	102	4	,	,	PUNCT
ajlm-2617	102	5	hall	hall	PROPN
ajlm-2617	102	6	j	j	PROPN
ajlm-2617	102	7	,	,	PUNCT
ajlm-2617	102	8	foucar	foucar	NOUN
ajlm-2617	102	9	k.	k.	PROPN
ajlm-2617	103	1	how	how	SCONJ
ajlm-2617	103	2	i	i	PRON
ajlm-2617	103	3	investigate	investigate	VERB
ajlm-2617	103	4	monocytosis	monocytosis	NOUN
ajlm-2617	103	5	.	.	PUNCT
ajlm-2617	104	1	int	int	PROPN
ajlm-2617	104	2	j	j	PROPN
ajlm-2617	104	3	lab	lab	PROPN
ajlm-2617	104	4	hem	hem	PROPN
ajlm-2617	104	5	.	.	PUNCT
ajlm-2617	105	1	2018;40:107–114	2018;40:107–114	PROPN
ajlm-2617	105	2	.	.	PUNCT
ajlm-2617	106	1	https://doi.org/10.1111/ijlh.12776	https://doi.org/10.1111/ijlh.12776	PROPN
ajlm-2617	106	2	troussard	troussard	PROPN
ajlm-2617	106	3	x	x	PROPN
ajlm-2617	106	4	,	,	PUNCT
ajlm-2617	106	5	maître	maître	NOUN
ajlm-2617	106	6	e	e	NOUN
ajlm-2617	106	7	,	,	PUNCT
ajlm-2617	106	8	paillassa	paillassa	ADJ
ajlm-2617	106	9	j.	j.	PROPN
ajlm-2617	106	10	hairy	hairy	ADJ
ajlm-2617	106	11	cell	cell	NOUN
ajlm-2617	106	12	leukemia	leukemia	NOUN
ajlm-2617	106	13	2024	2024	NUM
ajlm-2617	106	14	:	:	PUNCT
ajlm-2617	106	15	update	update	NOUN
ajlm-2617	106	16	on	on	ADP
ajlm-2617	106	17	diagnosis	diagnosis	NOUN
ajlm-2617	106	18	,	,	PUNCT
ajlm-2617	106	19	risk	risk	NOUN
ajlm-2617	106	20	-	-	PUNCT
ajlm-2617	106	21	stratification	stratification	NOUN
ajlm-2617	106	22	,	,	PUNCT
ajlm-2617	106	23	and	and	CCONJ
ajlm-2617	106	24	treatment	treatment	NOUN
ajlm-2617	106	25	-	-	PUNCT
ajlm-2617	106	26	annual	annual	ADJ
ajlm-2617	106	27	updates	update	NOUN
ajlm-2617	106	28	in	in	ADP
ajlm-2617	106	29	hematological	hematological	ADJ
ajlm-2617	106	30	malignancies	malignancy	NOUN
ajlm-2617	106	31	.	.	PUNCT
ajlm-2617	106	32	am	be	AUX
ajlm-2617	106	33	j	j	PROPN
ajlm-2617	106	34	hematol	hematol	NOUN
ajlm-2617	106	35	.	.	PUNCT
ajlm-2617	107	1	2024;99(4):679–696	2024;99(4):679–696	X
ajlm-2617	107	2	.	.	PUNCT
ajlm-2617	108	1	https://doi.org/10.1002/ajh.27240	https://doi.org/10.1002/ajh.27240	PROPN
ajlm-2617	108	2	national	national	PROPN
ajlm-2617	108	3	health	health	PROPN
ajlm-2617	108	4	laboratory	laboratory	PROPN
ajlm-2617	108	5	service	service	NOUN
ajlm-2617	108	6	(	(	PUNCT
ajlm-2617	108	7	nhls	nhls	PROPN
ajlm-2617	108	8	)	)	PUNCT
ajlm-2617	108	9	.	.	PUNCT
ajlm-2617	109	1	placement	placement	NOUN
ajlm-2617	109	2	of	of	ADP
ajlm-2617	109	3	full	full	ADJ
ajlm-2617	109	4	blood	blood	NOUN
ajlm-2617	109	5	count	count	NOUN
ajlm-2617	109	6	haematology	haematology	NOUN
ajlm-2617	109	7	analysers	analyser	NOUN
ajlm-2617	109	8	for	for	ADP
ajlm-2617	109	9	nw	nw	PROPN
ajlm-2617	109	10	/	/	SYM
ajlm-2617	109	11	fs	fs	PROPN
ajlm-2617	109	12	,	,	PUNCT
ajlm-2617	109	13	limp	limp	ADJ
ajlm-2617	109	14	/	/	SYM
ajlm-2617	109	15	mp	mp	NOUN
ajlm-2617	109	16	,	,	PUNCT
ajlm-2617	109	17	gp	gp	NOUN
ajlm-2617	109	18	,	,	PUNCT
ajlm-2617	109	19	kzn	kzn	PROPN
ajlm-2617	109	20	,	,	PUNCT
ajlm-2617	109	21	ec	ec	PROPN
ajlm-2617	109	22	and	and	CCONJ
ajlm-2617	109	23	wc	wc	PROPN
ajlm-2617	109	24	/	/	SYM
ajlm-2617	109	25	nc	nc	PROPN
ajlm-2617	109	26	regions	region	NOUN
ajlm-2617	109	27	including	include	VERB
ajlm-2617	109	28	service	service	NOUN
ajlm-2617	109	29	and	and	CCONJ
ajlm-2617	109	30	maintenance	maintenance	NOUN
ajlm-2617	109	31	for	for	ADP
ajlm-2617	109	32	a	a	DET
ajlm-2617	109	33	period	period	NOUN
ajlm-2617	109	34	of	of	ADP
ajlm-2617	109	35	five	five	NUM
ajlm-2617	109	36	(	(	PUNCT
ajlm-2617	109	37	5	5	NUM
ajlm-2617	109	38	)	)	PUNCT
ajlm-2617	109	39	years	year	NOUN
ajlm-2617	110	1	[	[	X
ajlm-2617	110	2	homepage	homepage	NOUN
ajlm-2617	110	3	on	on	ADP
ajlm-2617	110	4	the	the	DET
ajlm-2617	110	5	internet	internet	NOUN
ajlm-2617	110	6	]	]	PUNCT
ajlm-2617	110	7	.	.	PUNCT
ajlm-2617	111	1	roche	roche	PROPN
ajlm-2617	111	2	diagnostics	diagnostic	NOUN
ajlm-2617	111	3	(	(	PUNCT
ajlm-2617	111	4	pty	pty	NOUN
ajlm-2617	111	5	)	)	PUNCT
ajlm-2617	111	6	ltd	ltd	PROPN
ajlm-2617	111	7	;	;	PUNCT
ajlm-2617	111	8	2022	2022	NUM
ajlm-2617	111	9	[	[	X
ajlm-2617	111	10	cited	cite	VERB
ajlm-2617	111	11	2024	2024	NUM
ajlm-2617	111	12	jul	jul	NOUN
ajlm-2617	111	13	12	12	NUM
ajlm-2617	111	14	]	]	PUNCT
ajlm-2617	111	15	.	.	PUNCT
ajlm-2617	112	1	available	available	ADJ
ajlm-2617	112	2	from	from	ADP
ajlm-2617	112	3	:	:	PUNCT
ajlm-2617	112	4	https://nhlsqa1.nhls.ac.za/placement-of-full-blood-count-haematology-analysers-for-nw-fs-limp-mp-gp-kzn-ec-and-wc-nc-regions-including-service-and-maintenance-for-a-period-of-five-5-years-6/	https://nhlsqa1.nhls.ac.za/placement-of-full-blood-count-haematology-analysers-for-nw-fs-limp-mp-gp-kzn-ec-and-wc-nc-regions-including-service-and-maintenance-for-a-period-of-five-5-years-6/	PROPN
ajlm-2617	112	5	ramiah	ramiah	PROPN
ajlm-2617	112	6	j	j	PROPN
ajlm-2617	112	7	,	,	PUNCT
ajlm-2617	112	8	pillay	pillay	PROPN
ajlm-2617	112	9	d	d	PROPN
ajlm-2617	112	10	,	,	PUNCT
ajlm-2617	112	11	rapiti	rapiti	PROPN
ajlm-2617	112	12	n.	n.	PROPN
ajlm-2617	112	13	performance	performance	NOUN
ajlm-2617	112	14	of	of	ADP
ajlm-2617	112	15	the	the	DET
ajlm-2617	112	16	automated	automate	VERB
ajlm-2617	112	17	sysmex	sysmex	NOUN
ajlm-2617	112	18	xn-3000	xn-3000	PROPN
ajlm-2617	112	19	analyser	analyser	NOUN
ajlm-2617	112	20	for	for	ADP
ajlm-2617	112	21	detecting	detect	VERB
ajlm-2617	112	22	white	white	ADJ
ajlm-2617	112	23	blood	blood	NOUN
ajlm-2617	112	24	cell	cell	NOUN
ajlm-2617	112	25	abnormalities	abnormality	NOUN
ajlm-2617	112	26	in	in	ADP
ajlm-2617	112	27	south	south	PROPN
ajlm-2617	112	28	africa	africa	PROPN
ajlm-2617	112	29	.	.	PUNCT
ajlm-2617	113	1	afr	afr	PROPN
ajlm-2617	113	2	j	j	PROPN
ajlm-2617	113	3	lab	lab	PROPN
ajlm-2617	113	4	med	med	PROPN
ajlm-2617	113	5	.	.	PUNCT
ajlm-2617	114	1	2023;12(1):2140	2023;12(1):2140	NUM
ajlm-2617	114	2	.	.	PUNCT
ajlm-2617	115	1	https://doi.org/10.4102/ajlm.v12i1.2140	https://doi.org/10.4102/ajlm.v12i1.2140	PROPN
ajlm-2617	115	2	joubert	joubert	PROPN
ajlm-2617	115	3	j	j	PROPN
ajlm-2617	115	4	,	,	PUNCT
ajlm-2617	115	5	weyers	weyer	NOUN
ajlm-2617	115	6	r	r	PROPN
ajlm-2617	115	7	,	,	PUNCT
ajlm-2617	115	8	raubenheimer	raubenheimer	PROPN
ajlm-2617	115	9	je	je	PROPN
ajlm-2617	115	10	.	.	PUNCT
ajlm-2617	116	1	reducing	reduce	VERB
ajlm-2617	116	2	unnecessary	unnecessary	ADJ
ajlm-2617	116	3	blood	blood	NOUN
ajlm-2617	116	4	smear	smear	NOUN
ajlm-2617	116	5	examinations	examination	NOUN
ajlm-2617	116	6	:	:	PUNCT
ajlm-2617	116	7	can	can	AUX
ajlm-2617	116	8	sysmex	sysmex	VERB
ajlm-2617	116	9	blood	blood	NOUN
ajlm-2617	116	10	cell	cell	NOUN
ajlm-2617	116	11	analysers	analyser	NOUN
ajlm-2617	116	12	help	help	VERB
ajlm-2617	116	13	?	?	PUNCT
ajlm-2617	117	1	med	med	ADJ
ajlm-2617	117	2	technol	technol	PROPN
ajlm-2617	117	3	sa	sa	PROPN
ajlm-2617	117	4	.	.	PROPN
ajlm-2617	117	5	2014;28(1):6–12	2014;28(1):6–12	NUM
ajlm-2617	117	6	.	.	PUNCT
ajlm-2617	118	1	grever	grever	PROPN
ajlm-2617	118	2	mr	mr	PROPN
ajlm-2617	118	3	,	,	PUNCT
ajlm-2617	118	4	abdel	abdel	PROPN
ajlm-2617	118	5	-	-	PUNCT
ajlm-2617	118	6	wahab	wahab	PROPN
ajlm-2617	118	7	o	o	PROPN
ajlm-2617	118	8	,	,	PUNCT
ajlm-2617	118	9	andritsos	andritsos	PROPN
ajlm-2617	118	10	la	la	PROPN
ajlm-2617	118	11	,	,	PUNCT
ajlm-2617	118	12	et	et	PROPN
ajlm-2617	118	13	al	al	PROPN
ajlm-2617	118	14	.	.	PUNCT
ajlm-2617	119	1	consensus	consensus	NOUN
ajlm-2617	119	2	guidelines	guideline	NOUN
ajlm-2617	119	3	for	for	ADP
ajlm-2617	119	4	the	the	DET
ajlm-2617	119	5	diagnosis	diagnosis	NOUN
ajlm-2617	119	6	and	and	CCONJ
ajlm-2617	119	7	management	management	NOUN
ajlm-2617	119	8	of	of	ADP
ajlm-2617	119	9	patients	patient	NOUN
ajlm-2617	119	10	with	with	ADP
ajlm-2617	119	11	classic	classic	ADJ
ajlm-2617	119	12	hairy	hairy	ADJ
ajlm-2617	119	13	cell	cell	NOUN
ajlm-2617	119	14	leukemia	leukemia	NOUN
ajlm-2617	119	15	.	.	PUNCT
ajlm-2617	120	1	blood	blood	NOUN
ajlm-2617	120	2	.	.	PUNCT
ajlm-2617	121	1	2017;129(5):553–560	2017;129(5):553–560	NUM
ajlm-2617	121	2	.	.	PUNCT
ajlm-2617	121	3	https://doi.org/10.1182/blood-2016-01-689422	https://doi.org/10.1182/blood-2016-01-689422	PROPN
ajlm-2617	121	4	furundarena	furundarena	PROPN
ajlm-2617	121	5	jr	jr	PROPN
ajlm-2617	121	6	,	,	PUNCT
ajlm-2617	121	7	sainz	sainz	PROPN
ajlm-2617	121	8	m	m	PROPN
ajlm-2617	121	9	,	,	PUNCT
ajlm-2617	121	10	uranga	uranga	PROPN
ajlm-2617	121	11	a	a	PRON
ajlm-2617	121	12	,	,	PUNCT
ajlm-2617	121	13	et	et	PROPN
ajlm-2617	121	14	al	al	PROPN
ajlm-2617	121	15	.	.	PROPN
ajlm-2617	121	16	comparison	comparison	NOUN
ajlm-2617	121	17	of	of	ADP
ajlm-2617	121	18	abnormal	abnormal	ADJ
ajlm-2617	121	19	cell	cell	NOUN
ajlm-2617	121	20	flagging	flagging	NOUN
ajlm-2617	121	21	of	of	ADP
ajlm-2617	121	22	the	the	DET
ajlm-2617	121	23	hematology	hematology	NOUN
ajlm-2617	121	24	analyzers	analyzer	NOUN
ajlm-2617	121	25	sysmex	sysmex	NOUN
ajlm-2617	121	26	xn	xn	PROPN
ajlm-2617	121	27	and	and	CCONJ
ajlm-2617	121	28	sysmex	sysmex	NOUN
ajlm-2617	121	29	xe-5000	xe-5000	PROPN
ajlm-2617	121	30	in	in	ADP
ajlm-2617	121	31	oncohematologic	oncohematologic	ADJ
ajlm-2617	121	32	patients	patient	NOUN
ajlm-2617	121	33	.	.	PUNCT
ajlm-2617	122	1	int	int	NOUN
ajlm-2617	122	2	j	j	PROPN
ajlm-2617	122	3	lab	lab	NOUN
ajlm-2617	122	4	hematol	hematol	NOUN
ajlm-2617	122	5	.	.	PUNCT
ajlm-2617	123	1	2017;39(1):58–67	2017;39(1):58–67	X
ajlm-2617	123	2	.	.	NOUN
ajlm-2617	123	3	https://doi.org/10.1111/ijlh.12575	https://doi.org/10.1111/ijlh.12575	PROPN
ajlm-2617	123	4	alaggio	alaggio	PROPN
ajlm-2617	123	5	r	r	PROPN
ajlm-2617	123	6	,	,	PUNCT
ajlm-2617	123	7	amador	amador	PROPN
ajlm-2617	123	8	c	c	PROPN
ajlm-2617	123	9	,	,	PUNCT
ajlm-2617	123	10	anagnostopoulos	anagnostopoulos	PROPN
ajlm-2617	123	11	i	i	PROPN
ajlm-2617	123	12	,	,	PUNCT
ajlm-2617	123	13	et	et	PROPN
ajlm-2617	123	14	al	al	PROPN
ajlm-2617	123	15	.	.	PUNCT
ajlm-2617	124	1	the	the	DET
ajlm-2617	124	2	5th	5th	ADJ
ajlm-2617	124	3	edition	edition	NOUN
ajlm-2617	124	4	of	of	ADP
ajlm-2617	124	5	the	the	DET
ajlm-2617	124	6	world	world	PROPN
ajlm-2617	124	7	health	health	PROPN
ajlm-2617	124	8	organization	organization	NOUN
ajlm-2617	124	9	classification	classification	NOUN
ajlm-2617	124	10	of	of	ADP
ajlm-2617	124	11	haematolymphoid	haematolymphoid	ADJ
ajlm-2617	124	12	tumours	tumours	NOUN
ajlm-2617	124	13	:	:	PUNCT
ajlm-2617	124	14	lymphoid	lymphoid	ADJ
ajlm-2617	124	15	neoplasms	neoplasm	NOUN
ajlm-2617	124	16	.	.	PUNCT
ajlm-2617	125	1	leukemia	leukemia	NOUN
ajlm-2617	125	2	.	.	PUNCT
ajlm-2617	126	1	2022;36(7):1720–1748	2022;36(7):1720–1748	X
ajlm-2617	126	2	.	.	PUNCT
ajlm-2617	127	1	doi	doi	NOUN
ajlm-2617	127	2	:	:	PUNCT
ajlm-2617	127	3	10.1038	10.1038	NUM
ajlm-2617	127	4	/	/	SYM
ajlm-2617	127	5	s41375	s41375	PROPN
ajlm-2617	127	6	-	-	PUNCT
ajlm-2617	127	7	022	022	NUM
ajlm-2617	127	8	-	-	PUNCT
ajlm-2617	127	9	01620	01620	NUM
ajlm-2617	127	10	-	-	SYM
ajlm-2617	127	11	2	2	NUM
ajlm-2617	127	12	.	.	PUNCT
ajlm-2617	127	13	erratum	erratum	NOUN
ajlm-2617	127	14	in	in	ADP
ajlm-2617	127	15	:	:	PUNCT
ajlm-2617	127	16	leukemia	leukemia	NOUN
ajlm-2617	127	17	.	.	PUNCT
ajlm-2617	128	1	2023;37(9):1944–1951	2023;37(9):1944–1951	NUM
ajlm-2617	128	2	.	.	PUNCT
ajlm-2617	129	1	https://doi.org/10.1038/s41375-022-01620-2	https://doi.org/10.1038/s41375-022-01620-2	NUM
ajlm-2617	129	2	sysmex	sysmex	NOUN
ajlm-2617	129	3	corporation	corporation	NOUN
ajlm-2617	129	4	.	.	PUNCT
ajlm-2617	130	1	chapter	chapter	NOUN
ajlm-2617	130	2	15	15	NUM
ajlm-2617	130	3	:	:	PUNCT
ajlm-2617	130	4	p.	p.	NOUN
ajlm-2617	130	5	466–469	466–469	NUM
ajlm-2617	130	6	.	.	PUNCT
ajlm-2617	131	1	in	in	ADP
ajlm-2617	131	2	:	:	PUNCT
ajlm-2617	131	3	automated	automate	VERB
ajlm-2617	131	4	hematology	hematology	NOUN
ajlm-2617	131	5	analyzer	analyzer	NOUN
ajlm-2617	131	6	xn	xn	PROPN
ajlm-2617	131	7	series	series	PROPN
ajlm-2617	131	8	transportation	transportation	NOUN
ajlm-2617	131	9	units	unit	NOUN
ajlm-2617	131	10	(	(	PUNCT
ajlm-2617	131	11	xn-9000	xn-9000	PROPN
ajlm-2617	131	12	/	/	SYM
ajlm-2617	131	13	xn-9100	xn-9100	PROPN
ajlm-2617	131	14	)	)	PUNCT
ajlm-2617	131	15	.	.	PUNCT
ajlm-2617	132	1	instructions	instruction	NOUN
ajlm-2617	132	2	for	for	ADP
ajlm-2617	132	3	use	use	NOUN
ajlm-2617	132	4	.	.	PUNCT
ajlm-2617	133	1	(	(	PUNCT
ajlm-2617	133	2	ver.22	ver.22	NOUN
ajlm-2617	133	3	)	)	PUNCT
ajlm-2617	133	4	.	.	PUNCT
ajlm-2617	134	1	kobe	kobe	PROPN
ajlm-2617	134	2	:	:	PUNCT
ajlm-2617	134	3	sysmex	sysmex	NOUN
ajlm-2617	134	4	corporation	corporation	NOUN
ajlm-2617	134	5	;	;	PUNCT
ajlm-2617	134	6	2021	2021	NUM
ajlm-2617	134	7	.	.	PUNCT
ajlm-2617	134	8	sysmex	sysmex	NOUN
ajlm-2617	134	9	corporation	corporation	NOUN
ajlm-2617	134	10	.	.	PUNCT
ajlm-2617	135	1	chapter	chapter	NOUN
ajlm-2617	135	2	5	5	NUM
ajlm-2617	135	3	:	:	PUNCT
ajlm-2617	135	4	p.	p.	NOUN
ajlm-2617	135	5	66–71	66–71	NOUN
ajlm-2617	135	6	.	.	PUNCT
ajlm-2617	136	1	in	in	ADP
ajlm-2617	136	2	:	:	PUNCT
ajlm-2617	136	3	automated	automate	VERB
ajlm-2617	136	4	hematology	hematology	NOUN
ajlm-2617	136	5	analyzer	analyzer	NOUN
ajlm-2617	136	6	xn	xn	PROPN
ajlm-2617	136	7	-	-	PUNCT
ajlm-2617	136	8	l	l	NOUN
ajlm-2617	136	9	series	series	NOUN
ajlm-2617	136	10	(	(	PUNCT
ajlm-2617	136	11	xn-530	xn-530	PROPN
ajlm-2617	136	12	/	/	SYM
ajlm-2617	136	13	xn-430	xn-430	PROPN
ajlm-2617	136	14	/	/	SYM
ajlm-2617	136	15	xn-330	xn-330	PROPN
ajlm-2617	136	16	)	)	PUNCT
ajlm-2617	136	17	.	.	PUNCT
ajlm-2617	137	1	general	general	ADJ
ajlm-2617	137	2	information	information	NOUN
ajlm-2617	137	3	(	(	PUNCT
ajlm-2617	137	4	ver.5	ver.5	PROPN
ajlm-2617	137	5	)	)	PUNCT
ajlm-2617	137	6	.	.	PUNCT
ajlm-2617	138	1	kobe	kobe	PROPN
ajlm-2617	138	2	:	:	PUNCT
ajlm-2617	138	3	sysmex	sysmex	NOUN
ajlm-2617	138	4	corporation	corporation	NOUN
ajlm-2617	138	5	;	;	PUNCT
ajlm-2617	138	6	2020	2020	NUM
ajlm-2617	138	7	.	.	PUNCT
ajlm-2617	139	1	sysmex	sysmex	PROPN
ajlm-2617	139	2	south	south	PROPN
ajlm-2617	139	3	africa	africa	PROPN
ajlm-2617	139	4	scientific	scientific	ADJ
ajlm-2617	139	5	customer	customer	NOUN
ajlm-2617	139	6	services	service	NOUN
ajlm-2617	139	7	.	.	PUNCT
ajlm-2617	140	1	customer	customer	NOUN
ajlm-2617	140	2	literature	literature	NOUN
ajlm-2617	140	3	list	list	NOUN
ajlm-2617	140	4	–	–	PUNCT
ajlm-2617	140	5	white	white	ADJ
ajlm-2617	140	6	blood	blood	NOUN
ajlm-2617	140	7	cells	cell	NOUN
ajlm-2617	140	8	.	.	PUNCT
ajlm-2617	141	1	2024(03	2024(03	NUM
ajlm-2617	141	2	)	)	PUNCT
ajlm-2617	141	3	.	.	PUNCT
ajlm-2617	142	1	2024	2024	NUM
ajlm-2617	143	1	[	[	X
ajlm-2617	143	2	cited	cite	VERB
ajlm-2617	143	3	2024	2024	NUM
ajlm-2617	143	4	may	may	PROPN
ajlm-2617	143	5	31	31	NUM
ajlm-2617	143	6	]	]	PUNCT
ajlm-2617	143	7	.	.	PUNCT
ajlm-2617	144	1	available	available	ADJ
ajlm-2617	144	2	from	from	ADP
ajlm-2617	144	3	:	:	PUNCT
ajlm-2617	144	4	https://www.sysmex.co.za/academy/library/publications/	https://www.sysmex.co.za/academy/library/publications/	PROPN
ajlm-2617	144	5	schapkaitz	schapkaitz	PROPN
ajlm-2617	144	6	e	e	PROPN
ajlm-2617	144	7	,	,	PUNCT
ajlm-2617	144	8	raburabu	raburabu	PROPN
ajlm-2617	144	9	s.	s.	PROPN
ajlm-2617	144	10	performance	performance	NOUN
ajlm-2617	144	11	evaluation	evaluation	NOUN
ajlm-2617	144	12	of	of	ADP
ajlm-2617	144	13	the	the	DET
ajlm-2617	144	14	new	new	ADJ
ajlm-2617	144	15	measurement	measurement	NOUN
ajlm-2617	144	16	channels	channel	NOUN
ajlm-2617	144	17	on	on	ADP
ajlm-2617	144	18	the	the	DET
ajlm-2617	144	19	automated	automate	VERB
ajlm-2617	144	20	sysmex	sysmex	NOUN
ajlm-2617	144	21	xn-9000	xn-9000	PROPN
ajlm-2617	144	22	hematology	hematology	PROPN
ajlm-2617	144	23	analyzer	analyzer	PROPN
ajlm-2617	144	24	.	.	PUNCT
ajlm-2617	145	1	clin	clin	PROPN
ajlm-2617	145	2	biochem	biochem	PROPN
ajlm-2617	145	3	.	.	PUNCT
ajlm-2617	146	1	2018;53:132–138	2018;53:132–138	PROPN
ajlm-2617	146	2	.	.	PUNCT
ajlm-2617	146	3	https://doi.org/10.1016/j.clinbiochem.2018.01.014	https://doi.org/10.1016/j.clinbiochem.2018.01.014	PROPN